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SUMMARY
Hodgkin's disease (HD) is a malignant lymphoma characterised by the 
presence of the Reed Sternberg (RS) cell, the proposed malignant cell of 
the disease, in a polymorphous cellular background. The aetiology of 
HD is unknown and is the subject of this thesis. The RS cells account 
for around 1% of the tum our m ass and therefore characterisation of the 
RS cell has proven difficult. Epstein-Barr virus (EBV) has been detected 
in and localised to the RS cells in around 40% of HD tumours. The EBV 
latent membrane protein 1 (LMP-1) is expressed by the RS cells in EBV- 
positive cases. LMP-1 has been shown to up-regulate the B-cell 
lymphoma-2 [bcl-2] proto-oncogene and increased Bcl-2 expression is 
known to protect cells from apoptosis or programmed cell death. In 
addition the t(14; 18) translocation, which also causes increased Bcl-2 
expression, had been reported previously in HD. We investigated a 
series of HD cases for the presence of the t(14; 18) translocation utilising 
a  PCR technique. In a proportion of cases a comparison between LMP-1 
and Bcl-2 expression was made. We found few translocations present in 
the HD cases examined and in addition no correlation was observed 
between LMP-1 positivity and Bcl-2 expression. We conclude tha t the 
t(14; 18) translocation is an  infrequent finding in HD and is unlikely to 
play an  aetiological role in this malignancy.
An animal model for the study of HD would aid in studies such as that 
described above. The use of severe combined immunodeficient (SCID) 
mice for the study of hum an malignancies has been well documented. 
We attem pted to engraft HD-derived tum our tissue into SCID mice in 
order to propagate RS cells for the subsequent investigation of viral and 
oncogene involvement in this disease. In addition tum our cell 
suspensions from non-Hodgkin’s lymphoma (NHL) samples were also 
transplanted into SCID mice. The transplantation of NHL tum our cell 
suspensions was a success, with a proportion of tum ours in SCID mice 
showing identical genotype and phenotype to original biopsy material. 
The transplantation of HD tum our material into the SCID model was 
however less successful with SCID tum ours showing an EBV-driven 
lymphoproliferative phenotype indicating that outgrowth of EBV-infected 
bystander cells in the tum our had occurred. At present the SCID model 
appears an  unsuitable system for the propagation of the RS cells of HD.
XI
HD has a bimodal age incidence curve with a peak incidence in young 
adults; the cases within this peak particularly those of the nodular 
sclerosis subtype are infrequently EBV-associated. Epidemiological 
studies suggest that an  infectious agent may be involved in the aetiology 
of the young adult disease. Candidate infectious agents are 
herpesviruses since they are widespread in nature and establish 
persistent infection. We devised a PCR strategy for the detection of 
herpesvirus sequences in DNA samples using primers based on two well- 
conserved regions of the herpesvirus glycoprotein B gene. The assay has 
sufficient sensitivity to detect herpesvirus sequences if present within 
the RS cells of a  HD biopsy specimen. The assay also has the capability 
of distinguishing between different herpesviruses within a given sample. 
Use of a  technique such as this may show that another herpesvirus is 
involved in the pathogenesis of the non EBV-associated cases of HD.
XII
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CHAPTER 1 
GENERAL INTRODUCTION
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1
1.1.  CLASSIFICATION OF LYMPHOMAS
Hum an malignant lymphomas are broadly divided into two groups- 
Hodgkin's disease (HD) and the non-Hodgkin's lymphomas (NHLs) which 
can be further divided into B- and T-cell lymphomas (Stansfeld et aL, 
1988). | . Several systems
for the classification of lymphomas are in current use and are a m atter 
of some controversy (Lukes & Collins, 1975; Rosenberg, 1982; Bennett et 
a t,  1991). Ideally, lymphomas should be classified according to their 
presum ed normal counterpart, however our current knowledge does not 
permit reliable classification on this basis (Harris et aL, 1994). In 
contrast to the NHLs, the Rye classification system for the subdivision of 
HD (Lukes et aL, 1966) has remained stable and is generally accepted as 
pathologically relevant (Bennett et aL, 1991).
1.2. HODGKIN'S DISEASE
HD was first described in 1832 after a study involving the examination of 
seven lesions of the lymphatic glands and spleen (Hodgkin, 1832). The 
term  Hodgkin's disease was applied some 30 years later following 
examination of cases for clinical and gross pathological findings (Wilks, 
1865). The histology of HD was first described by Sternberg in 1898 and 
detailed further by Reed in 1902 (Sternberg, 1898; Reed, 1902). Both 
authors described the large bilobed or multinucleated giant cells now 
termed Reed-Stemberg (RS) cells which are characteristic of the disease. 
Both authors believed that the disease was infectious in nature; 
Sternberg proposed a Mycobacterial infection and Reed some other 
unknown agent.
1.2 .1 . Clinical features o f HD
HD most commonly presents with lymphadenopathy, often accompanied 
by constitutional 'B' symptoms including, tiredness, weight loss, fever 
and night sweats (Selby & McElwain, 1987). Common sites of 
lymphadenopathy a t presentation are the neck and mediastinal lymph 
nodes (Mauch etaL, 1993).
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1.2.2. H istopathological features o f HD
The diagnosis of HD is based on the recognition of the proposed 
malignant cell, the RS cell or morphological variant, present in a 
polymorphous cellular background (Lukes & Butler, 1966; Lukes, 1971). 
The cellular infiltrate is heterogeneous consisting of lymphocytes, 
histiocytes, granulocytes including eosinophils, plasma cells, and 
fibroblasts. The presence of the RS cell within an  appropriate cellular 
background is necessary for the diagnosis of HD as RS-like cells are also 
found in other conditions (Strum et aL, 1970).
1.2.3. H istopathological classification  o f HD
There is a range of histological appearances in HD and on this basis the 
disease has been divided into four subtypes: nodular sclerosis (NSHD), 
mixed cellularity (MCHD), lymphocyte depleted (LDHD) and lymphocyte 
predominance (LPHD). The earlier classification system of Lukes & 
Butler further subdivided the LDHD and LPHD categories as described 
in sections 1.2.3.3. and 1.2.3.4. The recent "REAL” lymphoma 
classification system suggests the inclusion of the provisional disease 
entity lymphocyte-rich classical HD in order to differentiate LPHD, as 
described below, from classical HD with abundant lymphocytes (Harris 
et aL, 1994). It is now recognised tha t LPHD is a distinct entity that 
should be classified separately from the other subtypes (Nicholas et aL, 
1990; Mason e ta l ,  1994).
1.2 .3 .1 . Nodular sclerosis HD
NSHD occurs mainly in young adults and in contrast to the other 
subtypes of the disease does not show a male predominance. NSHD 
accounts for 70% of cases and therefore is the most common histological 
subtype. The diagnosis relies on the histological detection of classical 
RS cells in a  polymorphous background including lacunar cells. There 
is prominent fibrosis with collagen bands dividing the node into nodules 
(Bennett et a t,  1991) (Fig 1.1.). The disease has been further divided
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Fig 1 .1 . H aem atoxylin a n d  Eosin s ta in ed  section from a  case
of NSHD (x 100 m agnification).
Photograph  kindly provided by Dr. A.S. Krajewski (D epartm ent
of Pathology, University of Edinburgh).
Fig 1.1. S ta in ed  se c tio n  o f a NSHD case
into good and poor prognostic categories termed NS-1 and NS-2 
respectively (MacLennan e t a l , 1989).
1 .2 .3 .2 . Mixed cellularity HD
MCHD occurs mainly in young adults, however it is also the most 
common subtype found in older patients and shows a male 
predominance. It accounts for between 20 and 40% of cases and is 
therefore the second most common subtype of the disease (Colby et a l,  
1982). The num ber of RS cells and the reactive cellular infiltrate in this 
subtype can be widely variable. Criteria for inclusion in this category are 
ill-defined as cases which do not fulfil the definition of NSHD or LPHD 
tend to be classified as MCHD. The cellular background may range from 
predominantly lymphocytic to lymphocyte depleted, although 
eosinophils, plasma cells and histiocytes are generally also observed. RS 
cell variants may be present and in addition areas of irregular sclerosis 
are sometimes observed (Fig 1.2.).
1 .2 .3 .3 . Lymphocyte depleted HD
LDHD can be sub-divided into two groups: diffuse fibrosis and reticular 
(Lukes & Butler, 1966). In present day studies this subtype accounts for 
less than  5% of cases and is therefore the least common (Kant et aL, 
1986). Diagnosis of the diffuse fibrosis subgroup is dependent on the 
detection of few classical RS cells and the presence of num erous large 
mononuclear variants of RS cells in a depleted cellular background. In 
the reticular subtype small num bers of lymphocytes, neutrophils and 
eosinophils are present along with cellular sheets of RS cells containing 
bizarre nuclei and mononuclear cells. Both subtypes are commonly 
observed within the same biopsy specimen.
1 .2 .3 .4 . Lymphocyte predominance HD
LPHD occurs at all ages and shows a marked male predominance. It 
accounts for around 5-10% of cases and is divided into nodular
4
Fig 1 .2 . H aem atoxylin an d  Eosin s ta in ed  section from  a  case
of MCHD (x 250  m agnification).
Photograph  kindly  provided by Dr. A.S. Krajewski (D epartm ent
of Pathology, U niversity of Edinburgh).
Fig 1.2. S ta in ed  se c tio n  o f a MCHD case
« ? * # * •  •
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lymphocytic and histiocytic predominance HD (NLPHD) and diffuse 
lymphocytic and histiocytic predominance HD (DLPHD) (Lukes & Butler, 
1966). This subgroup is characterised by the presence of L&H type RS 
cells tha t have multi-lobed nuclei and nucleoli tha t are less conspicuous 
than  those of classical RS cells. These cells are often referred to as 
"popcorn” cells. Few classical RS cells are present in this subtype 
(Wright, 1989; Butler, 1992). The distinctive phenotype of L&H cells 
suggests tha t they are of B-cell origin (Poppema et aL, 1979a, 1979b; 
Stein et aL, 1986). These cases are now described as a distinct clinical 
entity (Nicholas etaL, 1990; Mason etaL , 1994).
1.2.4. Im munophenotype and genotype o f RS cells
Immunophenotypic and genotypic studies in HD have been hampered by 
the relatively small proportion (often less than  1%) of RS cells within the 
tum our mass. Many studies have investigated the immunophenotype of 
RS cells using frozen and, in more recent years, paraffin sections from 
tum our biopsy material (reviewed by Hugh and Poppema, 1992; Drexler, 
1992). Activation-associated antigens such as CD71 (transferrin 
receptor), and CD25 (interleukin 2 receptor) have consistently been 
shown to be expressed in RS cells (Hugh and Poppema, 1992). Adhesion 
molecules have also been demonstrated, e.g., CD54 (ICAM-1), CD58 
(LFA-3), CD44 and CD 15 (Paietta, 1992). Members of the nerve growth 
factor receptor family, CD30 and CD40 are also expressed (Durkop et aL, 
1991; O’Grady et aL, 1994). CD30 is accepted as a  reliable marker for 
the identification of classical RS cells.
The lineage| of the classical RS cell is still unresolved. Inconsistent 
results have been obtained in studies using limited num bers of B- and 
T-cell m arkers on sections of paraffin-embedded tum our material (Hall et 
aL, 1988; Hugh & Poppema, 1992). In more detailed studies which 
employed the use of extended antibody panels, B-cell antigens were 
shown to be expressed by some of the RS cells in a large proportion of 
NSHD and MCHD cases (Schmid et aL, 1991). In contrast, other studies 
have shown that T-cell and not B-cell m arkers are expressed by RS cells 
in many cases of NSHD and MCHD (Agnarsson & Kadin, 1989; 
Dallenbach & Stein, 1989). The use of a novel technique involving the
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micromanipulation of single RS cells has allowed the study of gene 
expression within these cells (Trumper et aL, 1993). The results from 
this study demonstrated tha t the pattern of mRNA expression was 
consistent with tha t of an  activated haematopoeitic cell. The co­
expression of genes characteristic for different cell lineages however did 
not allow specific definition of the cellular origin of RS cells.
The use of T-cell receptor (TCR) and immunoglobulin (Ig) gene 
rearrangem ents as a marker of clonal proliferation is discussed in 
section 4.1. The analysis of TCR and Ig gene rearrangem ents in HD has 
been inconclusive. The proportion of cases with detectable 
rearrangem ent of Ig genes varies from 0-25% between studies (Knowles 
et aL, 1986; Griesser et aL, 1987; Herbst et aL, 1989; Gledhill et aL, 
1990). Studies which have selected cases on the basis of high RS cell 
num bers or enriched for RS cells have shown a higher proportion of 
rearrangem ents (Sundeen et aL, 1987; Weiss et aL, 1986). In several 
studies, the Ig genes in lesions containing large RS cell num bers were 
found to be in the germline configuration, clearly dem onstrating tha t Ig 
gene rearrangem ents are not present in all cases. The results of TCR 
analysis on HD specimens are equally controversial. In two reports a 
high incidence of TCR rearrangem ents was documented (Griesser et aL, 
1987; Herbst et aL, 1989) however other studies failed to confirm these 
findings (Gledhill et aL, 1990; Schmid et aL, 1991). These studies lend 
some support to the idea tha t RS cells are derived from lymphoid cells. 
There is also evidence suggesting tha t these cells may be derived from 
follicular dendritic reticulum cells (FDRCs) (Delsol et aL, 1993; 
Soderstrom et aL, 1994). In the first study CD21 expression was 
detectable in the RS cells of a proportion of cases. This antigen is also 
present in FDRCs. In the second study the FDRC marker, the acid 
cysteine proteinase inhibitor was detectable in RS cells in 88% of HD 
cases examined. Further studies are required to resolve this issue
1.2.5. Epidemiology o f HD
The majority of studies show a bimodal age incidence curve for HD 
although the age incidence peaks occur in different age groups in 
different situations (MacMahon, 1966). These differences have led to the
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suggestion that a t least three epidemiological patterns of HD exist 
(Correa & O'Conor, 1971).
In developing countries the first peak of the bimodal curve occurs in 
childhood, there is a decrease in incidence in the third decade and a 
second peak occurs in older age groups. In developed countries, there is 
a  low incidence in childhood but this increases with age resulting in a 
pronounced peak in young adulthood (15-34 years). The incidence 
declines in the fourth decade and in older years a  gradual increase or 
plateau is observed (McKinney et a l,  1989; Glaser & Swartz, 1990). An 
intermediate pattern is found in rural areas of developed countries, in 
central Europe and in the southern United States (Alexander et a l , 
1991a; Correa & Conor, 1971).
NSHD has a unimodal age incidence and accounts for the young adult 
peak seen in developed countries. In childhood, NSHD is relatively less 
common. The other subtypes as a group show a gradual increasing 
incidence with age which is a similar pattern to tha t observed for other 
lymphomas (McKinney et a l, 1989; Glaser & Swartz, 1990). There is a 
male predominance which is most pronounced in children and older 
adults and there is evidence tha t female cases in the young adult group 
are increasing (McKinney etaL , 1989; Glaser & Swartz, 1990).
Several hypotheses have been suggested to explain the epidemiological 
features of HD. MacMahon proposed that HD is a heterogeneous 
condition comprising a t least three subgroups defined on the basis of 
age a t onset of disease (MacMahon, 1966). He defined the three age 
groups 0-14 years, 15-34 years and 50 years and over and suggested 
th a t the three groups had different aetiologies. Since tha t time 
epidemiological studies have confirmed that the risk factors for the 
young adult and older age groups differ giving rise to a "two disease" 
hypothesis (Gutensohn, 1982; Alexander etaL, 1991a).
An alternative, but not mutually exclusive, hypothesis suggests th a t HD 
results from delayed exposure to a common infectious agent. This is 
known as the delayed exposure hypothesis or late host response model. 
Epidemiological studies have shown an increased risk of developing HD 
in individuals with a high socio-economic sta tus in childhood (Alexander
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et a l,  1991b). It has been suggested tha t such persons have lacked 
early social contact and have therefore escaped infection with common 
childhood infections until later in life (Gutensohn & Cole, 1977). An 
extension of this hypothesis is the polio model which equates HD with 
paralytic polio in the prevaccine era (Gutensohn & Cole, 1981). This 
model suggests tha t like paralytic polio, HD in childhood in developing 
countries and young adult cases in developed countries are caused by 
the same infectious agent(s). These hypotheses are discussed further in 
section 1.4.1.1.
1.2.6. Aetiology o f HD
The aetiology of HD remains an enigma. Studies of viral and oncogene 
involvement in HD have been hindered by the paucity of the RS cells 
within the tum our mass. The propagation of RS cells in vitro for the 
subsequent investigation of the malignancy has been relatively 
unsuccessful and as yet no animal model is available for the study of 
HD.
In recent years the hum an herpesvirus Epstein-Barr virus (EBV) has 
been detected and localised to the RS cells in a proportion of HD cases. 
The significance of these findings is discussed in detail in section 1.4.1. 
and the investigation of involvement of other viruses is described in 
section 1.4.2. A PCR strategy for the detection of known or as yet 
uncharacterised hum an herpesviruses in HD tum our tissue is discussed 
in chapter 5.
Studies of oncogene involvement in HD have largely been restricted to 
analyses of HD-derived cell lines (Jucker et a l, 1990). These studies 
have given variable results and the in vivo significance of these findings 
is unclear. No consistent chromosomal abnormalities have been 
detected in HD by cytogenetic studies (Sandberg, 1990) however, in 
recent years, a possible role for the t(14; 18) translocation involving the 
IgH gene and the B-cell lymphoma-2 [bcl-2) gene has been suggested. 
The role of the bcl-2 gene is discussed in section 1.5. and our study 
investigating the presence of the t(14; 18) translocation in HD is 
discussed in detail in Chapter 3.
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Mutation of the p53 tum our suppressor gene is the most frequent 
abnormality detectable in hum an tum ours. Studies of p53 expression in 
HD have detected p53 in the RS cells of 32-74% of cases (Doglioni et a t, 
1991; Gupta e t a l f 1992a; Niedobitek eta L , 1993). Utilising a single cell 
PCR analysis Trumper et aL (1993), detected a m utation of the p53 gene 
in five out of seven RS cells in one case examined. These studies suggest 
tha t p53 may play a role in the pathogenesis of a proportion of HD cases.
1.3. HERPESVIRUSES
To date over 100 herpesviruses have been partially or fully characterised 
of which 7 have been isolated from hum ans. Herpesviruses are 
widespread and at least one herpesvirus has been found in association 
with most species.
1.3.1. Family Herpesviridae
Inclusion in the family Herpesviridae is based on the architecture of the 
virion which includes (a) a core containing a linear double-stranded DNA 
(dsDNA) (Furlong et a l , 1972), (b) an  icosahedral capsid, approximately 
100-110 nm in diameter (Wildy & Watson, 1963), (c) the tegument 
(Morgan et a l , 1959, 1968) and (d) an  envelope containing viral 
glycoproteins (Epstein, 1962). Herpesvirions have been reported to vary 
from 120-300 nm in size. DNA extracted from virions is linear and 
double-stranded ranging from 120-230 kilobases (kb) in length for the 
entire viral genome. Within the virion the DNA is linear however the 
genomes circularise immediately upon release from capsids into the 
nuclei of infected cells.
There are two distinct phases of the herpesvirus lifestyle known as lytic 
and latent phases. In the lytic cycle host cell DNA protein synthesis can 
be shu t off leading to host cell death (Wagner & Roizman, 1969). The 
ability to establish latent infection, in which a limited num ber of viral 
genes are expressed, is characteristic of herpesviruses (Roizman, 1982). 
EBV latent gene expression is discussed in section 1.3.4.2.
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1 .3 .2 . H erpesvirus g lycop rote in s
The herpesvirus membrane glycoproteins play a major role in the early 
stages of viral infection and are im portant in determining the biological 
and  pathogenic properties of the virus (reviewed by Spear, 1985). A 
num ber of glycoproteins of the alphaherpesvirus herpes simplex virus 1 
(HSV-1) have been identified (gB, gC, gD, gE, gG, gH, gl, gJ, gK and gL) 
(Spear, 1985; Hutchinson etaL , 1992).
Glycoprotein B (gB) was the first glycoprotein shown to be required for 
virus infectivity (Sarmiento et aL, 1979). It is the most highly conserved 
glycoprotein between herpesviruses, with HSV-1 gB being the prototype 
(Spear, 1985). Chapter 5 describes the use of a PCR strategy to detect 
herpesvirus gB sequences in DNA from clinical samples utilising primers 
based on two well conserved regions of the gB and gB-like genes.
1.3.3. Classification of herpesviruses
The members of the family Herpesviridae have been sub-classified by the 
International Committee on the Taxonomy of Viruses into three 
subfamilies based on biological properties including host range, site of 
latent infection, cytopathology and length of replicative cycle (Roizman, 
1992). These subfamilies are (a) alphaherpesvirinae, (b) 
betaherpesvirinae and (c) gammaherpesvirinae.
1.3.3.1. Alphaherpesvirinae
Members of the subfamily alphaherpesvirinae have a variable host range 
and  relatively short reproductive cycle. They have been shown to spread 
rapidly in culture with efficient destruction of infected cells. In addition, 
they have the capability of establishing latent infection which is 
primarily localised to the sensory ganglia. Members of this subfamily 
include HSV-1, HSV-2 and varicella zoster virus (VZV).
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1 .3 .3 .2 . B etaherpesvirinae
One characteristic of the subfamily betaherpesvirinae is the restricted 
host range. The reproductive cycle is long and infection in culture is 
slow. Infected cells often become enlarged (cytomegalia) and cultures 
carrying these viruses can be readily established. This subgroup also 
has the ability to establish latent infection and although this is generally 
observed in secretory glands and kidneys, other tissues may be infected. 
Hum an cytomegalovirus (HCMV) and the more recently identified hum an 
herpesviruses (HHV), HHV-6 & 7 have been assigned to this group.
1.3.3.3. Gammaherpesvirinae
All members of this subfamily have the ability to replicate in lymphoid 
cells in vitro. Lytic infection in epithelial and fibroblastic cells is also 
observed for some viruses of this group. Gammaherpesvirinae are 
specific for either T- or B-lymphocytes and infection is usually pre-lytic 
or lytic without production of infectious progeny. Latent virus infection 
is however frequently demonstrated in lymphoid tissue. Included in this 
group is the hum an herpesvirus EBV.
1.3.4. Epstein-Barr virus
EBV was originally identified in cultured lymphoblasts derived from 
Buridtt’s lymphomas (BLs) of African patients (Epstein et a l, 1964). The 
EBV genome is a linear dsDNA of around 170 kb in length that 
circularises upon entry into the infected cell. Circularisation occurs by 
the joining of multiple homologous terminal repeat sequences of 
approximately 500 base pairs (bp) in length (Pritchett et aL, 1975; 
Kintner & Sugden, 1979).
EBV is a hum an B-lymphotropic herpesvirus (Jondal & Klein, 1973; 
Greaves et a t, 1975) which is carried in a persistent state by over 90% of 
the worlds population (reviewed by Evans & Niederman, 1989). Primary 
infection generally occurs in early childhood and is asymptomatic. Early 
studies suggested tha t EBV infected oropharyngeal cells in the first
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instance (Sixbey et aL, 1984; Wolf et a l , 1984) and tha t the virus then 
spread from the epithelium to B-cells (Allday & Crawford, 1988). The 
exact site of persistence of the virus remains unclear, however recent 
reports suggest tha t B-cells are im portant in both primary infection and 
persistence of EBV (Niedobitek & Young, 1994). Late exposure and 
primary infection by the virus in adolescence or young adulthood results 
in the onset of a non-malignant lymphoproliferative disease, known as 
infectious mononucleosis (IM) or glandular fever, in approximately 50% 
of cases (Henle et a l , 1968). In addition to IM, a  num ber of malignant 
disease processes have now been associated with the virus including BL 
(Zur Hausen et a l, 1970), B-cell lymphomas in immunocompromised 
individuals (Hamilton-Dutoit et a l,  1993) and undifferentiated 
nasopharyngeal carcinoma (UNPC) (Klein, 1979). These tum ours exhibit 
different patterns of EBV gene expression as discussed in section
1.3.4.2. The precise role of EBV in these malignancies remains unclear. 
The association between EBV and HD is discussed in section 1.4.1.
1.3.4.1. EBV latent genes
Infection of hum an B-cells with EBV in vitro results in  their 
immortalisation and the creation of a  lymphoblastoid cell line (LCL) 
which is said to be latently infected (Pope et a l,  1968). The exact 
mechanism of immortalisation of B-cells remains unclear. A limited 
num ber of latent viral genes are expressed in LCLs and many studies 
have attem pted to characterise their function (Kieff & Liebowitz, 1990). 
Of these genes, six encode nuclear proteins known as EBV nuclear 
antigens (EBNAs) -1, -2, 3A, -3B, -3C and leader protein (EBNA-LP). 
Three membrane proteins designated latent membrane protein (LMP) -1, 
-2A, -2B are also expressed. In addition two small non-translated RNA 
species termed the EBV-encoded RNAs (EBERs) have been identified. 
Expression of three of these viral proteins has been shown to be 
necessary for the immortalisation of B-cells (reviewed by Ring, 1994).
EBNA-1 is a DNA binding protein which is required for the episomal 
m aintenance of the EBV genome (Yates et aL, 1984, 1985). The effect of 
EBNA-1 on malignant transformation remains unclear, however, 
expression of EBNA-1 in the B-cells of transgenic mice has been shown
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to be associated with the development of lymphocytic lymphoma and 
leukaemia (Wilson & Levine, 1992).
Current evidence suggests tha t EBNA-2 and LMP-1 are essential in the 
immortalisation process of B-cells. EBNA-2 has been shown to increase 
the expression of LMP-1 (Abbot et aL, 1990) and the B-cell activation 
antigen CD23 (Wang et a l, 1990). The induction of CD23 appears to be 
a critical event in the immortalisation process and is detected a t high 
levels in EBV immortalised B-lymphocytes (Kintner & Sugden, 1981).
LMP-1 has the ability to transform rodent fibroblasts in vitro and a t 
present is the only EBV latent gene product capable of transformation in 
isolation (Wang et a t, 1985). LMP-1 either singularly or in combination 
with EBNA-2 has been shown to upregulate CD23 (Wang et aL, 1987, 
1990). In addition LMP-1 has the ability to upregulate the bcl-2 gene as 
discussed in section 1.2.5.
1.3.4.2. Patterns o f EBV latent gene expression
In B-cells three patterns of expression of the EBV latent proteins have 
been described, designated Lat I, Lat II, and Lat III. In Lat I only the 
EBNA-1 protein is expressed. In Lat II, both EBNA-1 and the LMPs are 
expressed and in Lat III all of the EBV latent gene products are present 
(Rowe et a l, 1992). Various malignancies have been associated with 
different patterns of EBV gene expression. Lat I expression is seen in BL 
(Rowe et a l, 1986) whereas Lat III latency is observed in lymphomas in 
im m unosuppressed persons and is similar to tha t observed in LCLs 
(Young et a l, 1989). In UNPC an intermediate pattern, or Lat II is 
described (Young e ta l ,  1988).
1.3.4.3. EBV subtypes
Two strains of EBV have been described which differ in biological 
properties and can be distinguished immunologically and molecularly on 
the basis of differences in the EBNA-2 and EBNA-3 genes (Zimber et a l, 
1986; Young et a l, 1987; Sample et a l, 1990). EBV type A (or type 1)
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has been shown to transform cell lines more readily than  type B (or type 
2) in vitro (Rickinson et a l, 1987). Geographical differences between the 
two subtypes have indicated tha t EBV type 1 is the predominant subtype 
found in Western countries whereas type 2 is restricted to Papua New 
Guinea and Africa (Young et a l, 1987). Recent evidence, based on PCR 
subtyping suggests tha t type 2 virus may be more widely distributed in 
the West (Sixbey et a l, 1989).
1.4, VIRAL INVOLVEMENT IN HD
1.4.1. EBV in HD
The first association between EBV and HD was made on the basis of 
seroepidemiological studies which showed elevated antibody titres to 
EBV in cases compared to controls (Henle & Henle, 1973; Levine et a l, 
1971). Patients with a past history of IM, which is a  disease associated 
with late exposure to the EBV, have a three-fold increased risk of 
developing HD (Pagano et a l, 1973; Munoz et a l, 1978). Early studies 
failed to detect EBV genomes in HD tum our tissue (Lindahl et a l, 1974) 
however in later years EBV genomes were dem onstrated in 4 of 21 cases 
of HD utilising Southern blot analysis (Weiss et a l, 1987a). The 
sensitivity of detection of EBV in this study was enhanced by the use of 
cloned EBV probes, in particular a  probe to the major internal repeat 
sequence of the virus (Arrand et a l, 1981). Using similar methodology to 
th a t described above a number of laboratories have detected EBV in a 
proportion (up to 41%) of HD cases (Anagnostopoulos et a l, 1989; 
Boiocchi e ta l ,  1989; Gledhill e ta l ,  1991; Ja rre tt e ta l ,  1991).
The clonality of an EBV-infected cell population can be determined by 
analysis of the terminal repeat sequences of the EBV genomes using 
Southern blot analysis (Raab-Traub & Flynn, 1986). Using this 
methodology it has been shown tha t the EBV-infected cells in HD are 
clonal (Weiss et a l, 1989; Gledhill et a l, 1991). In more recent years the 
question of whether the EBV genomes are present in the RS cells or in 
the reactive infiltrate has been answered using probes directed a t the 
EBV EBER RNAs. The presence of these abundantly transcribed RNAs 
has enabled the development of a sensitive RNA in situ  hybridisation
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assay which can be performed on paraffin-embedded tissue (Howe & 
Steitz, 1986). The first study applying this technique in HD showed that 
EBV was present within the RS cell population in six of eight cases 
positive for EBV on Southern blot analysis (Wu et a l, 1990). In a  later 
study, RS cells from 16 of 17 cases which were EBV-positive on 
Southern blot analysis and shown to be clonal by this method were 
EBER-positive (Armstrong et a l, 1992b). These data suggest that, in a 
proportion of HD cases, EBV within the RS cells represents a clonal 
expansion of a  single EBV-infected cell. These findings have led u s to 
suggest th a t such cases should be designated EBV-associated 
(Armstrong et a l ,  1992b).
A num ber of studies have shown that LMP-1 is detectable within RS cells 
in  HD lesions (Pallesen et a l, 1991; Murray et a l,  1992; Armstrong et 
aL, 1992 a). This protein is highly expressed within the RS cells in the 
majority of cases shown to be EBV-positive by EBER in situ  techniques 
(Armstrong et a l, 1992b). The high level of LMP-1 expression by RS cells 
suggests tha t EBV is playing a role in the pathogenesis of the disease 
process. Indeed LMP-1 is known to upregulate a num ber of molecules 
including CD23, cellular adhesion molecules and the bcl-2 proto­
oncogene (section 1.3.4.1.). CD23 is expressed in the RS cells in a 
minority of cases but no clear association has been found between the 
expression of LMP-1 and CD23 in HD (Herbst et a l, 1991; Armstrong et 
a l,  1992b). We have further shown tha t the expression of bcl-2 does not 
correlate with the presence of EBV LMP-1 (Armstrong et a l, 1992a). The 
exact role played by LMP-1 in the pathogenesis of HD remains unclear. 
There is no evidence that EBNA-2 is expressed by RS cells however a 
recent study has confirmed the supposition tha t EBNA-1 is expressed 
(Grasser et a l,  1994). The pattern of EBV genome expression in HD 
therefore conforms to that designated Lat II (section 1.3.4.2.), a  pattern 
similar to tha t observed in UNPC.
1.4.1.1. EBV association with age in HD
It is clear tha t EBV is present in the RS cells of only a proportion of 
cases. Southern blot studies have reported an excess of EBV-positive 
cases in the MC subtype of HD in contrast to tha t seen in the NS
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subtype (Weiss et a l, 1987a; Staal et a l, 1989; Gledhill et a l, 1991). 
Most large studies using immunohistochemical or in situ  techniques to 
determine EBV sta tus have found a significant association between EBV 
positivity and MCHD as compared to NSHD (Pallesen et aL, 1991; 
Murray et aL, 1992; Armstrong et a l,  1994). The num ber of cases of 
LPHD and LDHD studied have generally been insufficient to accumulate 
statistically significant data, however, most LPHD cases have been EBV- 
negative (Weiss et a l,  1991; Pallesen et a l, 1991). Analysis of the 
relationship between EBV-positivity and age has revealed striking results 
(Jarrett et a l, 1991). In the latter study we dem onstrated tha t EBV 
genomes were detectable in tum our samples from m ost of the paediatric 
and older cases of HD examined. In contrast, within the young adult 
group EBV genomes were demonstrable in <15% of cases. This supports 
the "two disease” hypothesis proposed for HD (Gutensohn, 1982; 
Alexander et a l, 1991a). The low level of EBV-positivity within the 
young adult group, particularly those of NS subtype, would suggest that 
other factors are involved in these cases (Jarrett et a l, 1991).
More recently a comparison of EBV-association in paediatric cases of HD 
in developed and developing countries was made utilising the EBER in 
situ  hybridisation technique (Armstrong et a l, 1993). The results 
obtained confirmed previous findings tha t EBV was present in the 
majority of cases of childhood HD and, in particular, those under 10 
years of age. No significant differences were noted on comparison of 
geographical locale and different ethnic or socioeconomic backgrounds. 
The results of this study and those described above suggest tha t EBV- 
associated cases in HD fall into defined epidemiological groups. In the 
context of EBV-positivity these results do not provide support for the 
polio model but are consistent with the multiple aetiology hypothesis as 
discussed in section 1.2.5.
1.4.2. Other viruses in HD
EBV is rarely associated with young adult cases of HD, in particular the 
NS subtype, as described. It is in th is group tha t the strongest evidence 
exists for an  infectious aetiology. The delayed exposure hypothesis, as 
discussed in section 1.2.5., suggests tha t the infectious agent may be a
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common childhood pathogen. Possible candidates are herpesviruses 
other than  the EBV. At present serological studies have not shown an 
association between HD and the herpesviruses HSV, VZV and CMV 
(Henderson et a l, 1973; Langenhuysen et a l, 1974; Catalano & 
Goldman, 1972; Evans & Gutensohn, 1984). In contrast to these 
studies, several groups have reported elevated antibody titres to the 
herpesvirus HHV-6 in HD (Ablashi et a l , 1988; Biberfeld et aL, 1988; 
Clark et a l, 1990). In one study raised antibody levels to the virus were 
found to be most pronounced in young adult patients (Clark et a l,
1990). These studies suggested tha t HHV-6 may be aetiologically 
involved, however, HHV-6 DNA sequences were not detected in any of 47 
cases of HD using Southern blot analysis (Gledhill et a l, 1991). In a 
later study HHV-6 sequences were detected in 3 of 25 cases examined by 
Southern blot analysis or PCR and all three cases were young adult 
women with NSHD (Torelli et a l, 1991). These results are tantalising 
although HHV-6 genomes have not as yet been localised to the RS cells 
within HD tum our tissue. HHV-6 may play a role in a small proportion 
of cases however the low rate of genome positivity would suggest that 
HHV-6 is unlikely to account for the young adult peak. Another 
herpesvirus may be involved in these cases. Chapter 5 describes a PCR 
technique for the detection of herpesvirus sequences in DNA from HD 
tum our material.
1.5. BCL-2
One of the most prevalent chromosomal translocations found in hum an 
lymphoma is the t(14; 18) (q32;q21) and the location of the IgH gene on 
chromosome 14q32 provided a m eans to clone this juncture. An 
aberrant IgH gene rearrangem ent proved to be the chromosomal 
breakpoint and the subsequent analysis revealed a candidate proto­
oncogene bcl-2 at position 18q21 (Cleary & Sklar, 1985; Bakhshi et a l, 
1985; Tsujimoto et a l, 1985). The translocation is associated with >75% 
of follicular lymphomas and 30% of diffuse lymphomas (Yunis et a l, 
1987; Weiss et a l, 1987b). Approximately 60% of the translocations 
occur within a specific region designated the major breakpoint region or 
m br (Cleary & Sklar, 1985; Bakhshi e t a l , 1987).
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As described above the translocation juxtaposes the bcl-2 gene situated 
on chromosome 18 with the IgH gene on chromosome 14. This causes 
dysregulation of the bcl-2 gene and inappropriate levels of Bcl-2 are 
expressed (Graninger et aL, 1987; Seto et aL, 1988). A num ber of 
studies have shown that abundant bcl-2 mRNAs are expressed in all 
t(14; 18) carrying cell lines (Tsujimoto et aL, 1985; Cleary et aL, 1986; 
Chen-Levy, 1989). Transgenic mice bearing a bcl-2 fig  mini gene were 
found to exhibit a  polyclonal expansion of resting B-cells which 
displayed prolonged cell survival bu t no increase in cell cycling 
(McDonnell et aL, 1989, 1990). In addition, dysregulated Bcl-2 protein 
expression has been shown to extend the survival of certain 
haematopoeitic cells lines following growth factor deprivation (Vaux et 
aLf 1988; Nunez e t a l , 1990).
The expression of Bcl-2 is not restricted to cells carrying the t(14; 18) 
translocation (Pezella et a l , 1990) and Bcl-2 is highly expressed in 
normal pre-B cells bu t down-regulated in m ature B-cell lines. It has 
now been demonstrated that Bcl-2 is a membrane protein and that 
overexpression of this protein blocks programmed cell death and thereby 
increases cell survival (Hockenbery et a t, 1990). The subcellular 
location of Bcl-2 is controversial, however Bcl-2 protein in 
overexpressing cells has been shown to be associated with the nuclear 
envelope and endoplasmic reticulum as well as with the mitochondria 
(Jacobson e t a l ,  1993).
Activation of EBV latent gene products has been shown to protect 
hum an B-cells from apoptosis (Gregory e t aL, 1991). Transfection 
experiments have confirmed that this protection from apoptosis is 
conferred through the expression of a single latent gene product, LMP-1. 
These experiments showed that LMP-1 mediated this effect by 
upregulating the expression of Bcl-2 (Henderson et aL, 1991). Chapter 3 
discusses the investigation of the t(14; 18) translocation in HD and 
correlates results with both Bcl-2 and LMP-1 expression.
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1.6 . SCID MICE
CB-17 severe combined immunodeficient (SCID) mice are characterised 
by a homozygous mutation of the SCID locus in the mouse which 
disrupts both B-and T-cell lymphoid development. This results in low 
serum  Ig levels and the lack of functional T-cells (Bosma et a l, 1983). 
The defect has been mapped to chromosome 16 in the mouse (Bosma & 
Carroll, 1991; Miller et a l, 1993). The lack of functional B-and T-cells is 
due to a  defect in V(D)J recombination (reviewed by Bosma & Carroll,
1991). In addition SCID mice have a defect in DNA double-stranded 
break-related repair (Hendrickson e ta l ,  1991).
Although SCID mice have a severe immune deficit the overall ability of 
these mice to support lymphoid development is not impaired. The 
deficiency of m ature B-and T-cells can be corrected by engrafting adult 
SCID mice with bone marrow or fetal liver cells from normal mice 
(Bosma et a l, 1983; Custer et a l, 1985). These initial observations 
prompted other investigators to attem pt the xenogeneic engraftment of 
hum an lymphoid cells into SCID mice (Mosier et a l, 1988; McCune et 
a l, 1988). The success of these experiments and others in more recent 
years (Lubin et a l, 1991; Lapidot et a l, 1992) have encouraged the use 
of the SCID mouse as a model for the investigation of hum an disease.
Many different diseases have now been investigated using the SCID 
mouse model (reviewed by Hendrickson, 1993) including multiple 
myeloma (Bellamy et a l, 1993), leukaemia (Cesano et a l, 1993; Kamel- 
Reid et a l, 1989; Lapidot et a l, 1994) and hum an lymphoma (Gamier et 
a l, 1993; Boyle et a l, 1992). In addition SCID mice have been used to 
support the in vivo growth of hum an lymphoma cell lines (Chang et aL,
1992) and lymphomas from immunosuppressed post-transplantation 
patients (Waller et a l, 1993). The study of viral infections in this model 
has also been reported in the literature e.g., hum an cytomegalovirus 
(HCMV) (Mocarski et a l, 1993). EBV-induced hum an B-cell 
lymphoproliferations have been more extensively studied. Between 30% 
and 80% of SCID mice develop hum an B-cell lymphoproliferations 
following transplantation of lymphocytes from EBV-seropositive donors 
(Mosier e ta l ,  1992; Nakamine e ta l ,  1991; Rowe e ta l ,  1991).
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j Recently attem pts have been made to utilise the SCID mouse model for
j  the study and investigation of HD. Kapp et aL, (1992) showed tha t HD-
| derived cell lines which could not be propagated in nude mice grew in
SCID mice. In this study tum our growth was also observed in SCID 
mice following injection of primary HD tum our material. In another 
study successful transplantation of a  HD-derived cell line (HD-MyZ) into 
SCID mice gave rise to a large tum our m ass with the presence of RS-like 
cells and  a phenotype similar to tha t of the parental in vitro cell line 
(Bargou e ta l ,  1993).
The only previously reported study of transplantation of HD into SCID 
mice described 3 /1 3  cases in which B cell lymphoma developed following 
transplantation of HD tum our fragments (Kapp et a l , 1993). The 
aforementioned studies would suggest tha t the SCID mouse model may 
be a useful tool for the in vivo study of HD and perhaps aid the further 
characterisation of the malignancy. These implications are discussed in 
further detail in chapter 4, which describes our attem pt to engraft 
tum our material derived from HD and NHL tum our biopsies into SCID 
mice.
1.7. AIMS OF PROJECT
The aim s of this study were to investigate the involvement of oncogenes 
and viruses in the pathogenesis of HD. The presence of the t(14;18) 
translocation was investigated and the results correlated with Bcl-2 and 
EBV LMP-1 expression. In order to study the role of other oncogenes 
and viruses we explored the use of the SCID mouse model as a m eans to 
propagate HD tum our material. In addition a new strategy was devised 
for the search for herpesvirus sequences in HD. This will be used to 
determine whether a herpesvirus other than  EBV is present in the non 
EBV-associated cases of the disease, in particular, young adult NS 
cases.
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CHAPTER 2  
GENERAL MATERIALS AND METHODS
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2 .1 . MATERIALS
The following chapter describes the materials and m ethods frequently 
used in the work relating to this thesis. The sources of commonly used 
materials are listed in Table ILL and the composition of routinely used 
stock solutions and buffers in Table ILII. Additional materials and 
chemicals not listed are specified elsewhere in the text. All chemicals
|TM
used were of Analar or Molecular Biology grade and unless otherwise 
stated were obtained from The Sigma Chemical Company Limited (Poole, 
Dorset, UK) or BDH (Poole, Dorset, UK). All restriction and DNA 
modifying enzymes were obtained from Life Technologies (Gibco/BRL, 
Paisley, UK). Ultra pure de-ionised water obtained from a reverse 
osmosis filtration system (Millipore) was used in all enzymatic 
m anipulations and for the re-suspension of DNA. De-ionised water 
obtained from a MilliQ water filtration system (Millipore) was used in all 
other procedures. S.I. units are used throughout this thesis.
2.2. MANIPULATION OF HIGH MOLECULAR WEIGHT DNA
2.2 .1 . DNA extraction from frozen tissue
Frozen tissue was disrupted using a Stomacher 80 (Colworth) after the 
addition of 5-25 mL of extraction buffer (Table II.II.). The volume of 
buffer added was dependent on tissue mass. Proteinase K was added to 
a  final concentration of 100 pg/mL and sodium dodecyl sulphate (SDS) 
to a concentration of 0.5%. The cell suspension was digested for 1 hour 
a t 50°C or overnight a t 37°C.
In order to remove protein from the tissue sample, an  equal volume of 
phenol equilibrated with Tris pH 8.0 (Rathbum Chemical Company, 
W alkerbum, UK) was added a t room tem perature and the tube was then 
slowly inverted, to allow aqueous and organic phases to mix completely. 
After centrifugation a t 2000 rpm for 10 m inutes (Denley BR401 
centrifuge) to separate the aqueous and organic phases, the upper 
aqueous phase was transferred to a  fresh tube. To prevent shearing of 
the high molecular weight (HMW) DNA, transfer was carried out using a 
wide bore polypropylene pastette (Alpha Labs). This procedure was
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Table II.I. Sources o f  routinely  u sed  m ateria ls
Materials Source
Apparatus for agarose gel electrophoresis BRL
Apparatus for polyacrylamide gel 
electrophoresis
Biorad
Corex centrifuge tubes (30 mL) Sarstedt
Falcon tubes (15 mL, 50 mL) A & J  Beveridge Ltd
Filter paper (Whatman) Fisons
1.5 mL screw cap tubes Elkay
Nylon membrane (Hybond-N) Amersham
Oakridge centrifuge tubes (30 mL) Sarstedt
Petri dishes Fisons
Pipette tips Greiner
Polaroid film (Type 57) Genetic Research 
Instrum entation
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Table II.II. S tock  so lu tion s and buffers
8% acrylamide solution acrylamide stock solution (30%) 260 mL/L
N,N methylene bisacrylamide (2%) 130 mL/L
TBE 1 X
Alkali buffer sodium hydroxide 0.5M
sodium chloride 
adjusted to pH 12.0
1.5M
D enhardt’s  solution (100 x) Ficoll 2%
Bovine serum  albumin (Fraction V) 2%
polyvinylpyrolidine 2%
Elution buffer (DEAE membrane) sodium chloride IM
Tris pH 9.0 50mM
EDTA ImM
DNA extraction buffer sodium chloride 144mM
Tris pH 8.0 lOmM
EDTA pH 8.0 ImM
10 x gel loading buffer bromophenol blue 0.42%
xylene cyanol 0.42%
glycerol 50%
Neutralising buffer Tris base 0.5M
sodium chloride 3M
concentrated hydrochloric acid 
adjusted to pH 8.0
3.3%
24
Table n .II. S tock  so lu tion s and buffers (continued)
Potassium acetate (3M/5M) potassium acetate stock solution (5M) 60 mL
glacial acetic acid 11 mL
deionised water to final volume 100 mL
SSC (IX) sodium chloride 0.5M
sodium citrate 0.015M
Southern hybridisation buffer Formamide 50%
sodium dodecyl sulphate 0.1%
Denhardt’s solution 5x
Tris pH 7.4 50mM
EDTA pH 8.0 lOmM
TAE Tris pH 8.0 40mM
sodium acetate 20mM
sodium chloride 20mM
EDTA pH 8.0 2mM
TBE Tris pH 8.0 90mM
boric acid 90mM
EDTA pH 8.0 2.25mM
TE Tris pH 8.0 lOmM
EDTA pH 8.0 ImM
TNE Tris lOmM
sodium chloride 0.1M
EDTA pH 8.0 ImM
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Table n .I I I . C om position  o f  bacteria l m edia
Luria-Bertani (LB) medium sodium chloride 170mM
bactotryptone 1%
bacto-yeast extract 
adjusted to pH 7.0
0.5%
L-Agar as LB medium with agar 1.5%
SOC bactotryptone 2%
yeast extract 0.5%
sodium chloride lOmM
potassium  chloride 2.5mM
magnesium chloride lOmM
magnesium sulphate lOmM
glucose
adjusted to pH 7.0
20mM
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was performed twice and then repeated using chloroform as the organic 
solvent.
The DNA was precipitated by pipetting the aqueous phase into 98% 
ethanol and whirling gently. Using a sealed glass pasteur pipette, the 
DNA precipitate was spooled from the ethanol. If the DNA appeared 
degraded, or if there were insufficient DNA to visualise the precipitate, 
the ethanol was placed in a 30 mL Corex tube and the DNA pelleted by 
spinning a t 10,000 rpm for 30 m inutes in a JA-20 rotor (Beckman 
Instrum ents Ltd, High Wycombe, UK). One millilitre of 70% ethanol was 
added to wash the pellet and to remove excess salt, followed by a final 
wash with 1 mL of 98% ethanol. The DNA was air dried a t room 
tem perature and resuspended in TE buffer (Table II.II.).
In order to assess the concentration of DNA, optical density (OD) 
readings at wavelengths of 260nm and 280nm were obtained using a 
spectrophotometer (Pharmacia Ltd, Milton Keynes, UK). The 
concentration of DNA was calculated on the basis tha t 50 [ig/mL of 
dsDNA has an O D 26onm °f 10 . The ratio of the O D 260nm to  the 
OD2gonm reading was obtained to assess the purity of the DNA sample.
2.2 .2 . Restriction endonuclease digestion o f HMW DNA
Ten micrograms of HMW DNA were digested in a 50 pL volume 
containing 1 x reaction buffer (Gibco/BRL, Paisley, UK) and spermidine 
a t a final concentration of 3 mM. Five units of the appropriate 
restriction endonuclease were added per \ig of DNA and the reactions 
were incubated at 37°C for 16-20 hours, to allow digestion to take place. 
Enzymatic reactions were stopped by the addition of EDTA (pH 8.0) to a 
final concentration of 10 mM, when digested samples would not be 
analysed immediately.
2.2 .3 . Agarose gel electrophoresis
Endonuclease-digested HMW DNA was electrophoresed on a  0.8% 
agarose gel unless otherwise stated. The agarose was dissolved by
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boiling in 1 x TBE buffer (Table II.II.) and the gel mix was then poured 
into a  Perspex tray and allowed to set a t room tem perature with a well- 
forming comb in place. The gel was completely submerged in 1 x TBE in 
an  electrophoresis tank, before carefully removing the comb. Gel loading 
dye was added to the digested DNA to a 1 x concentration and the gel 
was electrophoresed for 16-20 hours a t a  constant 32 V. A molecular 
weight standard, Lambda Hind III marker, was run  alongside the DNA 
sample to allow sizing of digested fragments. The DNA was stained by 
immersing the gel in a 0.5 pg/mL aqueous solution of ethidium bromide 
for 25 m inutes then destained by immersing in de-ionised water for 20 
minutes. The DNA was visualised on a transillum inator using short 
wave UV light (Foto/Prep I, Fotodyne Inc.) and photographed with a 
Polaroid MP40 Land camera using high speed Polaroid Type 57 film 
(Genetic Research Instrum entation Ltd, Dunmow, UK).
2.2 .4 . Southern blotting
Agarose gels were blotted by capillary action assisted by gravity. The 
gels were placed in alkali buffer for 40 m inutes to denature the DNA 
followed by a further 40 m inutes incubation in neutralisation solution. 
Prior to blotting, the gels were placed in 10 x SSC solution (transfer 
buffer) for 10 minutes. A piece of nylon membrane (Hybond-N, 
Amersham International pic, Little Chalfont, UK) was cut to gel size and 
pre-soaked in transfer buffer. DNA was transferred in a downward 
direction by placing the nylon membrane and gel on a layer of absorbent 
material and overlaying the gel with a  sponge saturated in transfer 
buffer. To prevent evaporation the blot was sealed in plastic wrapping 
and left for 16-20 hours to allow transfer to take place. In order to 
remove extraneous gel material, the nylon membrane was washed 
briefly in a  solution of 3 x SSC. DNA was irreversibly bound to the 
membrane by baking in an oven a t 80°C or by cross-linking with a  UV 
light source a t 120 joules/cm 2 for 0.8 m inutes (UV Stratalinker 1800, 
Stratagene).
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2 .3 . AMPLIFICATION AND PREPARATION OF PLASMID DNA
2.3 .1 . Transformation o f com petent bacteria
Competent bacteria, unless otherwise stated, were E. coli strain HB101 
obtained from Gibco/BRL. Bacterial cells were thawed on ice and a  100 
pL aliquot placed in a 2059 Falcon tube (A & J  Beveridge). Between 10 
and 100 ng of the appropriate plasmid DNA were added to the cells and 
placed on ice for 30 minutes. The mixture was heat shocked a t 42°C for 
45 seconds without agitation and placed immediately on ice for 2-3 
minutes. Nine hundred microlitres of L-broth or SOC (Table n.m.) were 
added and the reaction placed in a  shaking incubator for 1 hour. 
Bacteria were spread onto L-agar plates (Table II.III.) containing the 
appropriate antibiotic and placed a t 37°C overnight.
2.3 .2 . Growth of bacteria and amplification of plasmid DNA
Following transformation, a single colony was picked, using a sterile 
loop, into 5 mL of L-broth containing the appropriate antibiotic and 
placed a t 37°C with constant agitation overnight. The 5 mL culture was 
poured into a flask containing 500 mL of L-broth plus antibiotic and 
subsequently incubated overnight in an  orbital incubator a t 37°C.
2.3 .3 . Bacterial freezes
Bacterial freezes were routinely prepared from plasmids which had not 
previously been transformed into competent bacteria within this 
department. A 5 mL overnight culture was prepared from the 
appropriate plasmid-containing bacteria. One millilitre of the culture 
was added to 0.5 mL of 80% glycerol in water and was quickly frozen by 
placing in a beaker containing dry ice and 98% ethanol. The bacterial 
freeze was stored at -80°C.
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2 .3 .4 . Preparation o f  plasm id DNA
Following step 2.3.2., cells were harvested by centrifugation a t 7000 rpm 
for 10 m inutes (JS-7.5 rotor, Beckman). The supernatant was discarded 
and the cells washed in 100 mL of TNE buffer followed by a further 
centrifugation. Residual supernatant was removed and the pellet was 
resuspended in 4 mL of buffer containing 50 mM glucose, 10 mM EDTA, 
25 mM Tris.HCl and 0.5% lysozyme. After a  5 m inute incubation a t 
room temperature, 10 mL of an  alkali solution containing 0.2N NaOH 
and 1% SDS were added to the bacterial suspension and mixed 
thoroughly. The preparation was placed on ice for 10 minutes, before 
the addition of 12 mL of potassium acetate solution (Table II.II.) and 
incubation on ice for a further 10 minutes. The lysed bacteria were 
pelleted by centrifugation a t 19,000 rpm for 30 m inutes in a  JA-20 rotor 
(Beckman). The supernatant was decanted into two glass Corex tubes 
and 0.6 volumes of isopropyl alcohol were added and mixed to allow the 
precipitation of the plasmid DNA. The mix was spun for 30 m inutes at 
10,000 rpm in a JA-20 rotor and the supernatant removed. Five 
millilitres of 70% ethanol were added to the DNA pellet to remove salt 
followed by an additional spin at 10,000 rpm for 10 minutes. The pellet 
was left to drain briefly before resuspending in 5 mL of TE buffer. The 
plasmid DNA was purified on an ethidium brom ide/caesium  chloride 
gradient using methodology previously described by Maniatis et a t, 
(1982), and precipitated. Mini-plasmid preparations were performed on 
a smaller scale essentially as described above but without the addition of 
lysozyme in the initial resuspension step. The concentration of DNA was 
assessed spectrophotometrically as described in section 2.2.1. or by 
comparison of ethidium bromide staining intensity to tha t of known 
concentrations of DNA following agarose gel electrophoresis.
2.3 .5 . Digestion o f plasmid DNA
Plasmid digestions were carried out using similar methodology to that 
described in section 2.2.2. bu t with 1 pg of DNA as starting material and 
without the addition of spermidine. A two hour incubation a t 37°C was 
sufficient for digestion to take place. In order to check the authenticity 
of the plasmid, the digest was run  on a 0.8% agarose gel adjacent to 1 pg
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of Lambda Hind III DNA marker (Gibco/BRL). The gel was stained and 
photographed as described in section 2.2.3.
2.3 .6 . Preparation o f plasmid DNA insert for use as probe
Twenty five micrograms of the required plasmid were digested in a 200 
pL volume containing 1 x appropriate buffer (as supplied by 
manufacturer) and 3-5 units of restriction enzyme per pg of DNA, 
essentially as described in section 2.2.2. In order to check if digestion 
were satisfactory, 1% of the digestion mix was electrophoresed on an 
agarose gel. If satisfactory the remaining digestion was run  on a 0.8% 
agarose gel containing 0.5 pg/mL of ethidium bromide for 2-3 hours a t a 
constant 40 V or overnight a t 15 V.
Using a scalpel blade a small incision was made in the gel directly below 
the DNA fragment of interest. A piece of DEAE membrane (Schleicher 
and Schuell, West Germany) was cut to size and placed in the gel space. 
The gel was electrophoresed until the DNA fragment of interest had 
migrated onto the membrane. The membrane was removed and placed 
in sufficient elution buffer (Table II.II.) to cover the membrane, and 
incubated a t 65°C for 1 hour. To ensure tha t complete elution had 
taken place the membrane was examined for the presence of residual 
ethidium bromide-stained DNA using a  hand held short wave UV light 
source (model UVGL-58, UVP inc, USA). A phenol/chloroform extraction 
was performed as described in section 2.2.1. and after addition of NaCl 
to a final concentration of 0.4 M the DNA was precipitated in 2 volumes 
of ethanol a t -20°C for 1 hour. DNA was pelleted by centrifugation a t 
13000 rpm in a microcentrifuge (MSE) for 30 minutes. The pellet was 
washed briefly with a solution of 70% ethanol to remove extraneous salt 
and again pelleted as described above. The DNA pellet was briefly dried 
and resuspended in TE buffer or de-ionised water.
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2.4. THE USE OF RADIOACTIVELY-LABELLED PROBES
32P-radiolabelled probes were used for the specific detection and 
investigation of membrane-bound DNA target sequences.
2.4 .1 . Labelling o f DNA plasmid probes by random priming
The preparation of plasmid DNA for use as probe is described in section
2.3.6. Plasmid insert or linearised plasmid were labelled by random 
priming using a commercially available kit (Amersham International). 
Fifty nanograms of appropriate DNA in a 25 pL volume were denatured 
by boiling for 5 m inutes and placed immediately on ice to cool. Ten 
microlitres of buffer containing the nucleotides dATP, dGTP and dTTP in 
Tris-HCl, pH 7.8 with magnesium chloride and 2-mercaptoethanol were 
added to the plasmid solution. Five microlitres of bovine serum  albumin 
(BSA) containing random hexanucleotides were then added to the mix 
and this was pulsed briefly in a benchtop centrifuge (MSE 
microcentrifuge, Fisons Loughborough, UK). The DNA was labelled by 
the addition of 3 MBq of 32P-labelled alpha dCTP (specific activity 800 
Ci/mM) and 2 units of DNA polymerase I (Klenow fragment). The 
labelling reaction was placed at room tem perature for 4-15 hours.
In later experiments a radiolabelled nucleotide solution containing a 
coloured dye (Redivue, Amersham International) was utilised for ease of 
handling. Three Megabequerels of the 32P-labelled nucleotide (specific 
activity 3000 Ci/mM) were added and the reaction incubated for 30 
m inutes a t 37°C. Unincorporated nucleotides were removed from the 
reaction by Sephadex G50 (Pharmacia LKB) gel column filtration. 
Sephadex columns were either poured manually or commercial NICK 
columns (Pharmacia LKB) were used following the m anufacturers 
instructions.
2.4 .2 . Hybridisation with plasmid probes
Prior to hybridisation nylon filters containing bound DNA were soaked 
briefly in a solution of 3 x SSC, 0.1% SDS and placed in a 50 mL Falcon
32
tube (Table ILL) with the bound DNA on the inside of the tube. Two 
point five millilitres of the hybridisation buffer (Table II.II.) were added to 
the tube. The filters were pre-hybridised for a  minimum of 4 hours with 
continuous rotation a t 37°C to eliminate non-specific binding of probe. 
The hybridisation conditions were calculated utilising a formula similar 
to McConaughy et a t , (1969) where Tm  = 81.5+16.61og M+0.41(G+C%)- 
500/n-0.61(%formamide) where M is the salt concentration and n  the 
average probe size in bp. For the purposes of this calculation M=0.45 
and n=100. Hybridisations were routinely performed a t 25°C below the 
calculated Tm  of the DNA duplex in 50% formamide buffer. Following 
the addition of probe a t a concentration of 106 counts per m inute (cpm) 
per mL of buffer, hybridisation was performed with continuous rotation 
for 16-20 hours a t 37°C.
Filters were rinsed twice at room tem perature in 2 x SSC, 0.1% SDS for 
10 m inutes to remove excess probe. Further stringent washes were 
carried out at conditions appropriate for the permitted degree of 
mismatch between probe and target sequence. Routinely, two washes 
were performed a t 65°C in 0.5 x SSC, 0.1%SDS for 40 minutes. After 
removing excess moisture, the filters were wrapped in Saran wrap 
(Scotlab Bioscience Ltd, Coatbridge, UK) and placed with photographic 
film (Hyperfilm, Amersham International) in an  autoradiographic 
cassette containing an intensifying screen. The cassette was placed a t - 
20°C for 1-14 days before developing the film.
2.4 .3 . 5'-end labelling o f oligonucleotides
Oligonucleotides, for use as probes, were obtained as described in 
section 2.5.1. Five prime end-labelling reactions were performed in a 
100 pL volume containing 70 pmoles of oligonucleotide, 1 x kinase buffer 
(50 mM Tris pH7.5, 10 mM magnesium chloride, 5 mM DTT, 1 mM 
spermidine, 1 mM EDTA pH 8.0), 2 pL of T4 Polynucleotide kinase and 
70 pmoles of 32P yATP (3000 Ci/mM). Following incubation of the 
reaction for 1 hour at 37°C, unincorporated nucleotides were removed 
as described in section 2.4.1.
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2.4 .4 . Hybridisation with oligonucleotide probes
Following PCR amplification (section 2.5.2.) products were transferred to 
nylon membrane by electroblotting (section 2.5.7.) and radioactively- 
labelled oligonucleotides were used for the detection of specific PCR 
products. Hybridisation was performed using similar methodology to 
th a t described in section 2.4.2. a t 37°C with continuous rotation. After 
empirical testing, probes of 20-30 bp in length were hybridised in 25% 
formamide buffer (Table 11.11.) containing 6 x SSC. Probes 30-35 bp in 
length were hybridised in 35% formamide buffer containing 6 x SSC. 
One million cpm of probe were added per mL of hybridisation mix and 
the reaction allowed to proceed a t 37°C for 16-20 hours.
Filters were rinsed twice in a  solution of 6 x SSC, 0.1% SDS for 10 
m inutes a t room temperature, to remove excess probe. This was 
followed by two stringent washes a t 60°C for 30 m inutes in the wash 
solution described above. Filters were then briefly dried and exposed to 
film as discussed previously (section 2.4.2.).
2.5. THE POLYMERASE CHAIN REACTION
The specific PCR amplification of a target DNA sequence was achieved 
using methodology essentially as described by Saiki et aL, (1985). The 
procedures used and the optimisation of standard PCR techniques 
employed in this thesis are described below. Specific conditions and 
novel PCR techniques are detailed elsewhere in the text.
2.5 .1 . Oligonucleotide synthesis
Oligonucleotides for use as primers were m anufactured on an  automated 
synthesiser and cartridge purified unless otherwise stated (Alta 
Bioscience, University of Birmingham, UK). The primers were 
resuspended in ultra pure water and the concentration assessed as 
described in section 2.2.1. assum ing tha t 30 pg/mL of oligonucleotide 
has an OD260nm °f 10-
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Oligonucleotides for use as PCR probes were m anufactured on an 
autom ated synthesiser Model 381A (Applied Biosystems) within the 
Department of Veterinary Pathology. The oligonucleotides were cleaved 
from their cartridge by flushing with 2 mL of 30% ammonia solution over 
a  2 hour period. De-protection of the oligonucleotide was achieved by 
incubating in the ammonia solution a t 55°C overnight. The 
oligonucleotide was dried by centrifugation under vacuum (Savant 
Speedvac SC 100) and resuspended in water. The concentration of the 
DNA solution was assessed as described above.
2.5 .2 . Standard PCR reaction
Standard PCR reactions were performed in a 50 pL volume containing 
target DNA, 200 pM of each deoxynucleoside triphosphate (dATP, dGTP, 
dCTP, dUTP) (Cambio, Cambridge, UK), 1.5 mM magnesium chloride 
buffer containing 50 mM potassium chloride, 10 mM Tris pH8.2, 0.01% 
gelatin, primers a t the established optimal concentration (section 2.5.3.) 
and 1 unit of Amplitaq DNA polymerase (Perkin-Elmer). To prevent 
evaporation of the reaction mix during therm al cycling the reaction was 
overlaid with 2 drops of mineral oil.
The reaction mix was heated to 95°C for 7 m inutes to denature the DNA 
in a therm al cycling machine (Thermocycler, Perkin-Elmer) and forty 
cycles of amplification performed. In each cycle samples were ramped to 
a  tem perature of 94°C over 2 m inutes and held a t this tem perature for 
10 seconds. The temperature was then reduced to 55°C over 2 m inutes 
and the primers annealed for a 10 second period. To allow extension of 
the primers the tem perature was gradually increased to 72°C over a 1 
m inute period and held a t this tem perature for 30 seconds. A final 
primer extension time of 7 minutes a t 72°C was performed following 
completion of the thermal cycles. The reaction was then cooled to 6°C.
2.5 .3 . Optimisation o f primer concentration
Optimisation of primer concentration was achieved by titrating the 
primers from a concentration of 4 pM to 0.125 pM using doubling
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dilutions. The reaction was performed in a 50 pL volume using an 
appropriate am ount of positive control DNA as template. All other 
constituents and cycling conditions were as stated in section 2.5.2. The 
optimal concentration was assessed by visualisation of the PCR products 
following electrophoresis and ethidium bromide-staining of 
polyacrylamide gels (section 2.5.6.).
2.5 .4 . Optimisation of MgCl2 concentration
Optimal MgCl2 concentrations for individual primer pairs were assessed 
by varying the MgCl2 concentration from 3.0 mM to 0.5 mM in grades of 
0.5 mM. The PCR was performed as standard (section 2.5.2) and 
analysed as discussed in section 2.5.6. Primer sets generally optimised 
a t a concentration of 1.5 mM MgCl2 This concentration was used 
unless otherwise stated.
2.5 .5 . Avoidance o f contamination
In order to avoid any cross contamination from PCR products, reactions 
were set up  in a designated area with 'PCR-clean' pipettes using plugged 
or positive displacement pipette tips. A gown, gloves, mob cap and face 
m ask were worn. All products from PCR reactions were stored and 
analysed in a separate area from samples and PCR reagents. To further 
maximise this system all reagents for PCR were prepared and aliquoted 
outwith the Department of Veterinary Pathology.
The substitution of dUTP for dTTP within the PCR system facilitated the 
use of the enzyme uracil DNA glycosylase (Cambio) where contamination 
with PCR product was suspected. Prior to amplification, 1 un it of 
enzyme was ad d ed /100 pL reaction. The solution was heated to 37°C 
for 1 hour to allow breakdown of any contaminating product present. 
The initial denaturation in the standard PCR reaction, section 2.5.2., 
was increased from 5 to 10 m inutes to inactivate the enzyme.
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2 .5 .6 . A nalysis o f  PCR products
Products from PCR reactions were electrophoresed on 8% polyacrylamide 
gels (Table II.I.) on a  mini gel apparatus (Table ILIJ. Eight microlitres of 
sample with 2 pL of gel loading dye (Table II.IL) were loaded onto the gel 
and 400 ng of <|>X 174/Hae III m arker (Gibco/BRL) were run  on each gel 
as  a  size reference. The gel was ru n  for 1 hour a t 120 V then stained in 
a  0.5 pg/mL solution of ethidium bromide for 6 minutes. The DNA was 
visualised and the gel photographed as described previously (section
2.2.3.).
2.5 .7 . Electroblotting
Electroblotting was used for the transfer of PCR products from 
acrylamide gels to nylon membrane. Prior to blotting, gels were 
immersed in alkali buffer (Table 11.11.) for 8 m inutes to denature the DNA 
followed by immersion in neutralising buffer for a further 8 minutes. 
The gels were then placed in 1 x TAE transfer buffer (Table II.II.) before 
electroblotting. Transfer of DNA was performed using a mini- 
electroblotting apparatus (Bio Rad) and applying a constant 15 V across 
the gel for 1 hour. Following the blotting procedure DNA was bound to 
the membrane as described in section 2.2.4. Hybridisation with 
radiolabelled probe was performed to confirm the presence of specific 
product (section 2.4.4.).
2.6. CLONING OF PCR PRODUCTS
Prior to cloning, PCR products of interest were reamplified in a standard 
PCR reaction with the substitution of dTTPs for dUTPs. This 
reamplification was necessary as DNA containing dUTPs does not clone 
efficiently. Reamplification was performed by cutting a small piece of the 
PCR product of interest, amplified with dUTPs, from an  ethidium 
bromide-stained polyacrylamide gel. The gel slice was placed in a PCR 
tube and mashed using a pipette tip. The PCR was then performed as 
standard  (2.5.2.) bu t using dTTPs at a  concentration of 200 pM and the
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I acrylamide gel slice containing the PCR product as  template. The
resulting PCR product was then used as described below.
Cloning of PCR products was performed using a commercially available 
kit (TA cloning kit, Invitrogen). The TA cloning kit takes advantage of the 
non-template dependent activity of the thermostable polymerase used in 
PCR which adds a single deoxyadenosine to the 3' ends of duplex 
molecules. These 3' A-overhangs are used to insert the PCR product into 
a  vector which contains single 3' T-overhangs.
Following the m anufacturers instructions a ligation reaction was 
performed utilising the following formula to determine the am ount of 
PCR product to be ligated with 50 ng of supplied vector.
X ng PCR product = fY bo PCR productl f50 ng pCRm-Vectorl
size in bp of the pCR™ Vector
The ligation reaction was performed in an  11 pL volume containing 1 pL 
of lOx ligation buffer, 6 pL of sterile water, 2 pL of PCR vector, 1 pL of 
diluted PCR product and 1 pL of T4 DNA ligase. All components were 
supplied by the manufacturer. The reaction was placed a t 12°C for 4 
hours or overnight. The reaction was then transformed into One Shot™ 
competent cells following m anufacturers instructions. LB agar plates 
(Table n.III.) containing kanamycin or ampicillin antibiotic a t a 
concentration of 50 pg/mL were spread with 25 pL of X-Gal (40 mg/mL 
stock in dimethylformamide) to allow blue/white colony selection. Fifty 
and two hundred microlitre volumes of the transformed bacteria were 
spread onto the prepared plates and incubated overnight a t 37°C. White 
colonies were selected for analyses and grown overnight in 5 mL of L- 
broth containing appropriate antibiotic. Plasmid preparations were 
performed on a small scale essentially as described in section 2.3.4. or 
by using commercially available purification columns (mini-Wizard 
preparations, Promega). Plasmids were screened for insertion of PCR 
product DNA by restriction endonuclease digestion and polyacrylamide 
gel electrophoresis (sections 2.2.2. and 2.2.6. respectively). Clones of 
interest were sequenced commercially (Alta Bioscience).
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CHAPTER 3
LACK OF INVOLVEMENT OF THE BCL-2 GENE IN 
HODGKIN'S DISEASE
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3 .1 . INTRODUCTION
bcl-2 is a  proto-oncogene identified as a result of its involvement in the 
t(14;18)(q32;q21) chromosomal translocation which is characteristic of 
follicular lymphomas (Cleary & Sklar, 1985; Bakhshi et aL, 1985; 
Tsujimoto et a l , 1985). The translocation juxtaposes the bcl-2 gene 
situated on chromosome 18 with the IgH gene on chromosome 14 and as 
a  result the bcl-2 gene is dysregulated and inappropriate levels of the bcl- 
2  gene product are expressed (Graninger et a l,  1987; Seto et a l , 1988). 
Overexpression of Bcl-2 protein increases cell survival by protecting cells 
from undergoing programmed cell death or apoptosis (Hockenbery et aL,
1990). The translocation is associated with >75% of follicular 
lymphomas and 30% of diffuse lymphomas (Yunis et aL, 1987; Weiss et 
aL, 1987b). Approximately 60% of the translocations occur within a 
specific region designated the mbr region (Cleary & Sklar, 1985; Bakhshi 
et aL, 1987). The bcl-2 gene is discussed in section 1.5. of this thesis.
Stetler-Stevenson et aL (1990), detected t(14;18)(q32;q21) involving the 
m br of bcl-2 in samples from 32% of HD patients using a PCR technique. 
If the translocations in these cases were present in the RS cells and 
inappropriate levels of the bcl-2 gene product expressed, then this may 
contribute to increased survival of the tum our cells in HD. The EBV 
latent gene product LMP-1 has the ability to upregulate a num ber of 
cellular genes in vitro, including the proto-oncogene bcl-2 (Gregory et aL, 
1991; Henderson et al> 1991). Many studies have reported tha t EBV is 
associated with at least one third of HD cases. In these cases EBV 
genomes are present in RS cells and EBV LMP-1 is expressed (Weiss et 
a t,  1987a; Anagnostopoulos et a l  1989; Herbst et aL. 1991; Pallesen et 
aL, 1991; Armstrong etaL, 1992b).
Two different mechanisms may therefore lead to the induction of Bcl-2 in 
RS cells. Upregulation of the bcl-2 gene either by EBV infection or bcl-2 
translocation, may play a significant role in the pathogenesis of HD. To 
investigate this, the presence of t(14; 18) involving the m br was 
investigated in DNA samples derived from HD biopsy material of known 
EBV sta tus. Bcl-2 expression was also investigated in a subset of cases.
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3 .2 . MATERIALS AND METHODS
3.2.1 . Samples
Using a PCR strategy, DNA samples from fresh or frozen biopsies from 
50 patients with HD were investigated for the presence of translocations 
involving the mbr of bcl-2 and J H of the IgH gene. Samples were selected 
on the basis of availability of DNA and all had been assayed previously 
for the presence of EBV genomes. Twenty-seven cases were NSHD, 18 
MCHD, 1 LDHD and 4 LPHD. Thirty one were EBV-associated 
(Armstrong et a l, 1992b). A subset of 23 cases was examined for the 
presence of IgH gene rearrangements, in 6 cases rearrangem ents were 
detectable by Southern blot analysis (Gledhill et a l,  1990).
3.2 .2 . PCR analysis
The primers used in the PCR were modified versions of those used by 
Stetler-Stevenson et a l  (1990) (Fig 3.1.). Reactions were carried out in a 
50 pL volume containing 1 unit of thermostable polymerase (Cambio, 
Cambridge, UK), 25 pmols of each primer, 1 x buffer supplied with the 
enzyme and 200 pM of each deoxynucleoside triphosphate (dATP, dGTP, 
dCTP, dTTP). Two micrograms of DNA were used as template and in 
order to confirm the presence of amplifiable DNA, identical aliquots were 
assayed using primers derived from the EBV genome or from the beta- 
globin gene. Forty cycles of amplification were performed in a 
programmable heat block using standard therm al cycling param eters 
(section 2.5.2.).
3.2 .3 . PCR sensitivity and analysis o f product
DNA from a follicular lymphoma sample containing a bcl-2 translocation 
detectable on Southern blot analysis, was used to determine the 
sensitivity of the PCR. Starting with 2 pg of DNA, six serial 10-fold 
dilutions were assayed. Fourteen replicates of the 10-5 dilution were 
also assessed. DNA from a positive HD sample (case 9) had a similar
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titration performed, although in this instance, six replicates of each of 
the 10'4 and 10 5 dilutions were assessed.
Eight microlitres of products were electrophoresed on 8% polyacrylamide 
gels. Gels were subsequently stained and photographed, followed by a 
standard electroblotting procedure onto nylon membrane (sections 2.5.6. 
and 2.5.7.). Nylon filters were hybridised with 2.5 pmols of a 32P- 
radiolabelled internal oligonucleotide probe specific for the bcl-2 gene 
product (section 2.4.4.).
In each PCR experiment a negative control sample consisting of either 
water or placental DNA was assayed after every two HD samples. The 
majority of samples were assayed on more than  one occasion. A positive 
HD sample, case 9, was also included in each assay.
3.2 .4 . Immunostaining
Frozen sections from 11 of the above cases were stained using an 
indirect immunoperoxidase technique and a monoclonal antibody to the 
Bcl-2 protein (bcl-2 100). RS cells in 7 of the 11 cases were EBV LMP-1 
positive. Staining was carried out a t the Department of Pathology, 
University of Edinburgh by Dr. A.S. Krajewski and colleagues. Frozen 
material from the remaining cases was not available for assessm ent of 
the expression of the bcl-2 gene product.
3.2 .5 . Southern blot analysis
Southern blot analysis was used to determine whether the IgH or bcl-2 
loci were rearranged in samples from case 9. Probes used for 
hybridisation were a 3.5 kb probe to the IgH joining region (JH) (Erikson 
et a l , 1982) and a 4.3 kb probe to the m br of the bcl-2 locus. Standard 
Southern blot and hybridisation protocols were performed in each of 
these experiments (sections 2.2.4. and 2.4.2.).
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3 .3 . RESULTS
3.3 .1 . Polymerase chain reaction
Amplification products following PCR experiments were detectable on 
ethidium bromide-stained gels in the 10"4 dilution of the follicular 
lymphoma DNA sample. Following hybridisation, specific product was 
detected in 9 of the 14 replicates of the 10'® dilution.
Three of the fifty samples contained t[14; 18) translocations involving the 
m br of the bcl-2 loci detected using the above primers. Samples from 
cases 9 and 66 gave rise to specific amplification products, clearly visible 
on gels stained with ethidium bromide (Fig 3.1.). On repeated analyses, 
case 2 gave rise to a weak signal after hybridisation with the specific 
oligonucleotide probe. Amplified products from the three cases were of a 
different size, thus ruling out contamination due to carry-over of PCR 
product.
3.3 .2 . t(14; 18) positive cases
Case 2 was a 22 year old male with NSHD. The tum our was EBV- 
negative, LMP-1 negative and lacked TCR and IgH gene rearrangem ents 
on Southern blot analyses (Gledhill et aL, 1990).
Case 9 was a 50 year old female with a differential diagnosis of 
sclerosing mediastinal B-cell lymphoma and NSHD; on histological 
review 50% of the cells within this biopsy were considered malignant 
(Gledhill et a l, 1990). The tum our contained two IgH gene 
rearrangem ents detectable on Southern blot analysis (Gledhill et aL,
1991) and an  IgH gene rearrangem ent detectable by PCR using IgH V 
and J  region primers. Using Southern blot analysis rearrangem ent of 
the bcl-2 locus was not detected. The Southern blot analyses of case 9 
are shown in Fig 3.2. The tum our was EBV-positive and LMP-1 
expression was demonstrable (Gledhill et a l, 1991). The t(14; 18) 
translocation was detectable in 3 of 6 replicates containing the 10 4 
dilution of starting DNA, using the PCR methodology as described.
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Fig 3 .1 . PCR products following polyacrylamide gel 
electrophoresis and ethidium bromide-staining. PCR was 
performed using IgH/bcl-2 gene primers as detailed in the 
figure. Amplified IgH/bcl-2 gene products are detectable in 
samples from cases 66 and 9. Samples from cases 13, 71 and 
42 are negative. Detectable products are in the size range 118 
bp to 194 bp.
M= (j)X 174/H ae III marker; N= negative control (water).
Fig 3 .1 . Amplification products of bcl-2 / J h  PCR
^  ^  ^
^  On U> H 1 ^
194 bp— >
118 bp— >
u
w*
5’ prim er (bcl-2) :CTG TCG ACA CGG CCG TGT ATT ACT G 
3 ’ prim ers (J1-J5) :CTW ACC TGA RGA GAC GGT GAC C 
(J6) :CAA AGG CCC TAG AGT GGC CAT T 
W=A+T; R=A+G
Fig 3 .2 . Southern blot analyses of case 9 following restriction 
endonuclease digestion of sample DNA with Hind III enzyme. 
Fig A illustrates results obtained following hybridisation with 
an IgH (Jh) probe. Fig B illustrates results obtained following 
hybridisation with a bcl-2 gene probe. Sample DNA is on the 
left hand side and placental control DNA on the right hand 
side of both figures A and B.
G= germline; R= rearrangement.
Fig 3 .2 . Southern blot analyses of case 9
Fig A illu stra tes  two IgH gene rearrangem en ts  p re se n t in
case 9.
Fig B illu s tra te s  the germ line configuration  of th e  b c l-2  
gene of case 9.
Case 66 was a 66 year old male with HDNS and the tum our was EBV 
positive on Southern blot analysis (Jarrett et aL, 1991).
3.3 .3 . Immunophenotyping
Reliable assessm ent of Bcl-2 expression was not possible in any of the 
three cases positive for t(14;18), as frozen material was not available. 
Reactivity with the Bcl-2 monoclonal antibody was however clearly 
detected within the RS cells of 5 of the 11 cases examined (Armstrong et 
al., 1992b). Strong cytoplasmic staining was present in these cases 
although this was less intense than  tha t of the surrounding small 
lymphocytes. Three of seven EBV LMP-1 positive cases contained Bcl-2- 
positive RS cells. Control sections of normal lymph node showed 
staining of lymphocytes in paracortex and mantle zone bu t not in 
germinal centres.
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3 .4 . DISCUSSION
In th is study t(14; 18) involving the mbr of bcl-2 was detected in only 3 of 
50 cases examined. In case 9 the diagnosis of HD was in doubt and 
therefore the significance of this result is unclear. In conclusion, this 
chromosomal translocation would appear to be an  infrequent finding in 
HD. The bcl-2 gene product was detected in the RS cells of a  proportion 
of cases. The detection of t(14;18) did not correlate with EBV genome or 
LMP-1 positivity and Bcl-2 was present in the absence of the 
translocation.
Bcl-2 expression in RS cells, induced either by EBV or the t[14; 18) 
chromosomal translocation, would appear not to be a critical event in 
the pathogenesis of HD.
The findings from our group have subsequently been confirmed by 
similar studies using PCR based methodology (Said et a l ,  1991; Shibata 
et aL, 1990) or Southern blot analysis (Weiss et aL, 1987b; Athan et a l ,
1992). One study reported the absence of the t(14; 18) translocation 
involving both major and minor breakpoint regions of the bcl-2 gene in a 
series of 26 HD cases (Louie et a l, 1991). In a further PCR study 4 of 21 
HD cases examined contained translocations of this gene (Gupta et a l, 
1992b). In this study the authenticity of the translocations was 
confirmed by nucleotide sequencing. More recently the translocation 
was detected in 7 of 74 cases of HD using paraffin-embedded material as 
PCR template (Reid et a l, 1993). In this study two of the positive cases 
were confirmed by sequencing and in one case the nuclei were sorted 
into large and small sub-populations to attem pt to localise the 
translocation. In this case the t(14;18) signal was stronger in the large 
subpopulation of nuclei indicating tha t the translocation may be present 
in the RS cells. In a cytogenetic and PCR study rearrangem ent of the 
bcl-2 gene was detected in 40% of 28 HD biopsy specimens examined, 
however only 1 patient had a t(14;18) translocation in RS cells (Poppema 
etaL, 1992).
The differences between the results are difficult to interpret. A possible 
explanation is tha t differences in patient referral or histopathological 
classification, may affect the HD cases available for examination. The
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sensitivity of the assay in this type of study always comes under 
scrutiny. An evaluation of sensitivity in our assay indicates tha t if the 
translocation were present in greater than  1:100,000 cells it would have 
been detected. The tum our population in most cases will be greater 
than  this, therefore, if the t(14; 18) were present in these cells it would 
have been detected.
There is no direct evidence that the translocations detected by our group 
and others are present in the RS cell. It is necessary to clarify the 
cellular localisation of the translocation and in addition correlate these 
findings with Bcl-2 expression to ascertain the significance of the bcl-2 
gene in HD.
In case 9, if the translocation were present in the tum our population, 
which was estimated to be 50% of the cells, th is should have been 
demonstrable on Southern blot analysis. After repeated attem pts 
detection of this was not achieved, although the rearrangem ent involving 
the mbr of bcl-2 in a follicular lymphoma sample was easily 
demonstrable. In addition, two IgH gene rearrangem ents were clearly 
detectable in case 9 following hybridisation to an  IgH joining region 
probe using identical filters and similar methodology to tha t described 
above. Therefore, either the DNA fragment containing the translocation 
was present and migrating extremely close to the germline band making 
it difficult to distinguish the two, or, it was in a population of cells too 
small to detect by this method. A comparison of results from the PCR 
titration experiments performed on the follicular lymphoma sample and 
DNA from case 9, provides support for the latter interpretation. It is 
therefore possible that the clonal IgH gene rearrangem ents were present 
in a different population of cells from the bcl-2 translocation. Limpens et 
a l , (1991) have reported the detection of t(14;18)(q32;q21) in benign 
lymphoid tissues with reactive hyperplasia, thus the translocation is not 
exclusively associated with malignant cells.
The t(14; 18) translocations detected in the three samples in our study, 
may therefore have been present in the reactive component of the 
tumour. If this were the case, it is difficult to clarify the significance, if 
any, tha t this translocation has in the pathogenesis of HD.
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As discussed previously Stetler-Stevenson et a l , (1990) reported the 
detection of the t(14;18) translocation in a  proportion HD cases and 
implied tha t the gene may be involved in the pathogenesis of the disease. 
More recently Stetler-Stevenson's group have published a study where 
Bcl-2 expression in HD was investigated and correlated with the t(14; 18) 
translocation and EBV positivity (Bhagat et aL, 1993). In keeping with 
the results that we have found, this study could not correlate the 
presence of Bcl-2 staining in the RS cells with the presence of the 
t( 14; 18) translocation, or EBV positivity. In contrast to their earlier 
findings the conclusion was drawn tha t the translocation may not play a 
significant role in HD. In a different study a comparison between LMP-1 
positivity and Bcl-2 expression in RS cells of 53 cases of HD was made 
(Khan et aL, 1993). They concluded tha t EBV did not induce the 
expression of Bcl-2 in HD, however, the detection of Bcl-2 in the RS cells 
of 30% of cases led them to speculate tha t bcl-2 may play a  role in the 
EBV-negative cases. No investigation for the t(14;18) was made in this 
study.
The suggestion made by Reid et a t, (1993) tha t the rearrangem ent may 
be present in the RS cell population was not definitive and their results 
could not exclude the possibility tha t the translocation may be present 
in the reactive component of HD. Although Poppema et a t, (1992) found 
frequent abnormal karyotypes in RS cells the detection of t(14; 18) was 
an  infrequent finding. They concluded tha t the occurrence of a  bcl-2 
rearrangem ent in HD most likely resulted from the presence of small 
bystander B -lymphocytes in the reactive component of the tum our 
tissue.
There is now a consensus viewpoint tha t the bcl-2 gene has little 
significance in the pathogenesis of HD. Examination of the RS cells 
away from the reactive component of the tum our would assist in finally 
resolving this issue.
Localisation of the translocation or aberrant bcl-2 transcripts to a 
particular cell type would be required. To do this, PCR in situ  would 
assist in specifying which cell type is involved. Other possibilities 
include using single cell PCR techniques (Trumper et a l , 1993) or 
samples enriched for a particular cell type, to allow more specific studies
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to be performed. One possible method of tum our cell enrichment is the 
use of SCID mice to allow selective outgrowth of a clonal population of 
cells outwith the confines of an  immunological response.
When the above mentioned techniques are utilised successfully to study 
the RS cell then more specific and definitive conclusions can be made in 
studies such as this.
CHAPTER 4
TRANSPLANTATION OF HODGKIN'S DISEASE AND NON- 
HODGKIN'S LYMPHOMAS INTO SCID MICE
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4 .1 . INTRODUCTION
The aetiology of HD and cellular origin of the RS cell remain unclear. 
Attempts to characterise the malignant cells in HD, the RS cell and the 
mononuclear Hodgkin’s-like cells, have been unsuccessful. Despite 
extensive research utilising immunohistological and immunogenotypic 
analyses the lineage of the RS cell is unknown.
Difficulties are encountered while studying HD material due to the 
relatively small num bers of malignant cells present in the tum our mass. 
Attempts to purify RS cells have rarely been successful and cell lines 
derived from HD material have an  uncertain relationship to the tum our 
of origin. New strategies for the study of HD material are therefore 
necessary to study the tum our population of HD in greater detail.
One possible approach is the transplantation of HD tum our material into 
immunodeficient animals. This technique has been used successfully in 
the study of other hum an tum ours including NHLs. The use of SCID 
mice in the study of hum an malignancy is discussed in section 1.6. 
Recently SCID mice have been shown to support the growth of 
transplanted HD-derived cell lines (Kapp et a t , 1992). In two cases of 
HD, biopsy material was also successfully transplanted into SCID mice 
giving rise to EBV-positive hum an B-cell lymphoproliferations (Kapp et 
a t, 1992). At the present time EBV-negative lymphomas from HD 
material have not been described in the SCID mouse model.
In the present study the SCID mouse model was used for the study of 
both HD and NHLs. If the use of SCID mice could enable the outgrowth 
of a  relatively pure population of cells originating from hum an tum our 
cells then the applications would be both exciting and novel. For 
instance in recent years the study of the t(14; 18) translocation in HD 
has caused much controversy as it is not clear whether the translocation 
is present in the RS cell or in the reactive cellular infiltrate 
accompanying the tum our cell population (Chapter 3). Successful 
amplification of tum our cells in SCID mice would resolve this issue.
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Human tum our cells expanded in the SCID mouse model could also be 
used to study viral involvement in HD and NHLs, using assays such as 
tha t described in more detail in Chapter 5.
The induction of EBV-driven lymphoproliferations in SCID mice has 
been described in section 1.6. EBV proliferates in the SCID mouse 
model after engraftment of EBV-positive hum an tum our material. 
Generally this is seen as a polyclonal expansion of B-lymphocytes 
although active replication of the virus has undoubtedly taken place.
EBV is thought to play an aetiological role in the pathogenesis of certain 
subgroups of HD but is infrequently associated with the NSHD group, 
particularly cases within the young adult age incidence peak. 
Epidemiological studies support the hypothesis th a t an  infectious agent 
may be involved in the EBV-negative cases. A ubiquitous virus such as 
a herpesvirus would appear to be a candidate which would merit further 
investigation. If a different virus were present in HD, perhaps a new 
herpesvirus, then successful growth of tum our tissue in the SCID mouse 
model could give rise to valuable virus-rich material.
The aim of this study was to produce an  animal model to investigate the 
histogenesis, immunology and molecular biology of HD, outwith the 
confines of an  immunological response. Under these conditions selective 
outgrowth of the malignant cell population would allow more specific 
studies of HD to be completed. In order to clarify the relationship 
between tum ours arising in the SCID mice and the original HD tum our it 
is necessary to establish the clonality of both tum our types.
Molecular techniques have been used to determine the clonality and 
lineage of NHLs. Clonal B- and T-cell populations can be distinguished 
in tum our samples by the analysis of Ig and TCR gene rearrangem ents 
by Southern blot analysis (Arnold et a l , 1983; O'Connor et aL, 1985; 
Flug et a t ,  1987). In recent years the use of a PCR technique for the 
assessm ent of B-cell clonality has been described (McCarthy et a l, 1990; 
Dean & Norton, 1991). The procedure involves using standard PCR 
conditions with consensus primers to the V and J  regions of the IgH 
gene. This technique has the advantage tha t it requires relatively small 
am ounts of template DNA and the analysis is rapid thereby allowing
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increased throughput of test samples. Clonality of the tum our tissue in 
this study was assessed using PCR analysis of IgH gene rearrangem ents 
and in a proportion of cases Southern blot analysis of the IgH gene. In 
the EBV-positive cases Southern blot analysis of the terminal repeat 
sequences of the EBV genomes present was used to assess clonality of 
the EBV-infected cells.
Analysis of the clonality of EBV-infected cells is possible due to the 
variable num ber of tandem  repeat sequences present a t each end of the 
linearised EBV genome (Pritchett et a l, 1975; Kintner & Sugden, 1979). 
In EBV-infected cells the linear termini are joined intracellularly to form 
covalently closed episomal DNA, which is present in multiple copies, in 
both cell lines and tum our cells. In clonal cell lines established a t a 
multiplicity of infection (MOI) of less than  1, only one fused terminal 
restriction fragment is present (Kintner & Sugden, 1979). This gives rise 
to clonal EBV genomes which will contain identical num bers of terminal 
repeat sequences. In contrast, cell lines established a t a higher MOI 
have multiple fused terminal fragments (Raab-Traub et a l,  1980). This 
results in a polyclonally EBV-infected cell population which will have 
variable num bers of terminal repeat sequences from each of the EBV 
genomes present.
The following sections discuss the attem pt to engraft HD and NHLs into 
SCID mice and analysis of the resultant tum ours.
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4 .2 . MATERIALS AND METHODS
This project was undertaken in collaboration with Dr A.S. Krajewski 
(Department of Pathology, University of Edinburgh). The preparation of 
tum our cell suspensions and transplantation into SCID mice were 
performed a t the University of Edinburgh. Additional analyses 
performed a t the University of Edinburgh included immunophenotyping 
and in situ  hybridisation. The methodology for these techniques is 
stated below. All the molecular analyses were carried out by myself a t 
the LRF Virus Centre, University of Glasgow.
4.2 .1 . Preparation o f tumour cell suspensions
HD and NHL lymphoma lymph nodes and one spleen were obtained from 
the Royal Infirmary and the Western General Hospital, Edinburgh. Forty 
four biopsy specimens were prepared for injection into SCID mice 
including 18 HD, 23 NHL and 3 reactive nodes. Fresh lymph 
nodes/spleen were cut into small fragments in RPMI/L-Glutamine (ICN) 
solution and filtered through a fine mesh strainer. The suspension was 
centrifuged and the pellet resuspended in 1 mL of the above medium.
4 .2 .2 . Transplantation into SCID m ice
SCID mice (strain CB-17) were obtained from a colony, bred and 
m aintained in the Department of Medical Microbiology, University of 
Edinburgh animal house. SCID mice were injected between 6-10 weeks 
of age. Two hundred and fifty microlitres of tum our cell suspension, 
containing 0.7-7 x 107 cells, were given to each of four mice. Initially, 
different routes of injection were used (intraperitoneal, intravenous and 
subcutaneous) however after a few months, only the intraperitoneal 
route was employed.
Mice were sacrificed when there was detectable tum our or poor condition 
(10-20 weeks). To passage the tumour, a piece of the SCID tum our was 
made into a cell suspension and injected, as described above, into a 
further 4 mice.
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4.2 .3 . Immunophenotyping and in situ  hybridisation
Paraffin and frozen section immunophenotyping were carried out using a 
panel of T-cell, B-cell, monocyte and EBV markers. CD45 monoclonal 
antibodies were used to distinguish mouse and hum an tissue. EBER in 
situ  hybridisation was used as an  additional technique for the 
assessm ent of EBV status.
4.2 .4 . MOLECULAR ANALYSES
4.2 .4 .1 . Extraction of HMWDNA
HMW DNA was extracted from the majority of the above cases using a 
standard Proteinase K and SDS digestion, followed by phenol/chloroform 
extractions to remove protein (section 2.2.1.). Some samples were 
extracted using the Stratagene DNA extraction kit, which eliminated the 
use of solvents in the extraction procedure. The kit was used following 
the m anufacturers instructions and involved an initial digestion of tissue 
using Pronase enzyme, then removal of protein with an  SDS and sodium 
chloride solution, followed by precipitation of the DNA in ethanol. In 
both extraction procedures, if DNA were degraded or not sufficient to 
allow spooling, then the sample was spun gently in a bench-top 
centrifuge (MSE) to pellet the fragments of DNA. Although these samples 
were unsuitable for Southern blot analysis, they were used in PCRs, in 
which intact genomic DNA was not required.
4.2 .4 .2 . Southern blot analyses
Southern blot analysis (section 2.2.4.) was performed on the above 
samples, where intact DNA was available, for the investigation of EBV 
sta tus and subsequent analysis of the clonality of EBV genomes. Ten 
micrograms of genomic DNA were restriction enzyme digested, 
electrophoresed and capillary blotted, using standard protocols (sections 
2.2.2., 2.2.3. and 2.2.4., respectively).
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To investigate the presence of EBV in tum our samples, DNA digested 
with the restriction enzyme Bam HI was hybridised with the EBV Bam 
HI-W probe under standard conditions (sections 2.4.1. and 2.4.2.). The 
Bam HI-W probe is a sensitive probe since it represents the major 
internal repeat sequence of the EBV genome. The clonality of EBV- 
positive tum ours was assessed by hybridising DNA digested with Bam HI 
and Eco RI restriction enzymes with a 9 kb Eco RI-D insert probe 
(Arrand et a l ,  1981) which includes the terminal repeat sequences of the 
EBV genome. Restriction endonuclease digestion with Eco RI/Bam HI 
enzymes and subsequent hybridisation with the Eco RI-D probe, as 
described in section 4.2.5.2 gives rise to a constant 6 kb band visible 
following autoradiography in all EBV-positive samples. An additional 
fragment or fragments corresponding to the various terminal repeat 
sequences are also detectable. Therefore, where clonal EBV is present a 
6 kb band and another single band corresponding to the clonal terminal 
repeat sequence is present. If, however, a polyclonal EBV infection is 
present a ladder of bands representing the various EBV genomes is 
visualised in addition to the 6 kb band.
A proportion of cases were hybridised with an oligonucleotide probe 
(named Terminal 1) derived from sequences immediately 3' to the 5’ 
terminal repeat sequence or with a sub-clone of EcoR 1-D termed 
pBSLY3 derived from unique sequences situated 5f to the 3’ terminal 
repeats. Hybridisation and wash conditions were as described in section
2.4.4. Initially hybridised filters were exposed to autoradiographic film 
for 1 day, followed by a longer exposure as deemed appropriate.
4.2 .4 .3 . PCR analysis o f IgH gene rearrangement
In order to determine whether clonal B-cell populations were present 
within the tum our tissue a PCR was performed using DNA from original 
biopsy and SCID tum our specimens. The IgH PCR technique described 
in  this section allows different clones to be distinguished on the basis of 
size of amplified fragments. A clonal B-cell population results in a single 
fragment of a specific size for tha t particular rearrangement. Therefore, 
if an  identical clone were present in the original and SCID passaged 
tum our populations then an identical fragment size would be apparent.
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The primers used in the reaction were common variable and joining 
region primers homologous to the V and J  regions of the Ig H gene locus 
situated on chromosome 14. The primer sequences used are given in 
Table IV. I. PCR reaction conditions were optimised using a B-cell 
lymphoma DNA, shown to contain an  IgH gene rearrangem ent on 
Southern blot analysis, as template (sections 2.5.3. and 2.5.4.).
Frozen material from the original tum our from case 1372 was not 
available therefore paraffin sections were used for the analysis of IgH 
gene rearrangem ents by PCR.
Table IV.I. IgH PCR primer sequences
Prim er 5* 3’
1 (V) CTG TCG ACA CGG CCG TGT ATT ACT G
2 (J1-J5) CTC(T) ACC TGA G(A)GA GAC GGT GAC C
3 (J6) CAA AGG CCC TAG AGT GGC CAT T
Bases in parenthesis show alternative bases at two positions
One microgram of sample DNA was used as template in a PCR reaction 
containing 1 pM primers (1, 2 and 3, shown above). All other reaction 
components were as stated in section 2.5.2. A negative control sample 
containing water was included after every two samples. A B-cell 
lymphoma sample was used as a positive control in each experiment. 
S tandard PCR cycling conditions were performed (section 2.5.2.) and 
samples were analysed as discussed previously (section 2.5.6.).
In a  proportion of samples Southern blot analysis for the detection of IgH 
gene rearrangem ent was performed as described in section 3.2.5.
4 .2 .4 .4 . Bel-2 PCR and  Southern  b lo t analyses
Bcl-2 PCR identical to that described in section 3.2.2. was performed on 
case 1372 for the detection of the t(14;18) translocation and further 
assessm ent of the clonality of the passaged tum ours in this case. In 
addition Southern blot analysis with a bcl-2 probe was performed on this 
sample.
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4 .2 .4 .5 . D1S80 forensic DNA am plification k it for tum our typing
In th is type of study involving num erous mice, it is necessary to clarify 
tha t passaged material has indeed arisen from the original injected 
tum our cell suspension. During the investigation of tum our samples in 
this study it became apparent tha t definitive testing was required on the 
SCID mice and original material to confirm the relationship between the 
two. It is possible to distinguish samples from different individuals by 
their unique allelic pattern utilising a  PCR methodology.
The hum an genome contains large am ounts of repetitive DNA sequences 
which are arranged as tandem repeat units. Tandem repeat units are 
termed Variable Number of Tandem Repeats, or VNTRs (Nakamura et a t, 
1987). Discrimination between individuals is based mainly on the 
num ber of repeat units present and therefore VNTRs are considered 
'length” polymorphisms rather than  sequence polymorphisms. Analysis 
of VNTR loci is useful for investigation of forensic samples (Budowle et 
a t, 1991) and in our case, for clarifying the relationship between an 
original tum our sample and subsequent passaged tum our material.
The VNTR marker D1S80 consists of repeat units, 16 bp in length (Kasai 
et aL, 1990) and has been localised by multipoint linkage analysis to 
chromosome lp  (Nakamura et a l , 1988.). The 29 known alleles 
determine 435 possible genotypes with a discrimination power of 95-98% 
on the population. A commercial kit is available which enables such 
typing to be performed (Cetus Corporation).
During the course of this study a tum our sample from an HDNS case 
appeared to be successfully passaged in the SCID mouse model and had 
an EBV-negative profile and an IgH gene rearrangement. This sample 
appeared potentially exciting as to date, EBV-negative tum ours arising 
in SCID mice following transplantation of HD material have not been 
described. The results raised suspicion, however, when the IgH gene 
rearrangem ent derived from the passaged HD tum our was 
electrophoresed alongside an  IgH PCR product from a centroblastic 
lymphoma-derived SCID tumour. Both IgH gene rearrangem ents 
appeared identical in size which seemed highly unlikely due to the 
nature of rearrangement of the IgH gene locus. DNA from the original
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tum our and passaged tum our were typed for the VNTRs using the 
D1S80 forensic amplification reagent set following the m anufacturers 
instructions.
The tum our derived in the SCID mouse did not m atch tha t of the original 
tum our sample bu t was identical to the VNTRs of the original tum our 
from the case of centroblastic lymphoma. This particular HD case was 
therefore removed from the study.
An incident such as the one arising in  this situation is rare. However, 
the use of a simple PCR technique such as this can ensure tha t results 
obtained from SCID mouse tum ours bear a direct relationship to original 
biopsy tissue. Subsequently, all DNA from original tum our samples and 
passaged tum our tissue were typed using this methodology to establish 
a firm relationship between hum an tum our and SCID mouse-derived 
hum an tum our material.
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4 .3 . RESULTS
4 .3 .1 . D evelop m ent o f  lym phom as in  SCID m ice
Following injection and transplantation of tum our cell suspensions 5 /18  
HD and 6 /2 3  NHL cases showed the presence of detectable tum our 
following a latent period of between 11-20 weeks. No tum ours were 
detectable in mice following transplantation with reactive node tissue 
suspensions (3 cases). Usually only one animal per case developed 
lymphoma with the exception of case 2134 in which all anim als injected 
developed a tumour. Table IV.II. states the diagnosis and case num bers 
of the original tum ours which went on to develop lymphomas in the 
mice.
Table IV.II. Cases of HD and NHL transplanted into SCID mice
Diagnosis Case No.
LPHD 1371
LPHD 1145
LPHD 2593
NSHD 2507
MCHD 1373
Diagnosis Case No.
Centroblastic 1372
Centroblastic 2592
Centroblastic 2594
Immunoblastic 2620
Follicular CBCc 2506
Large cell anaplastic 2134(a)
Large cell anaplastic 2134(b)
CBCc=Centroblastic centrocytic
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4 .3 .2 . N ecropsy find ings
Only one animal developed a subcutaneous tumour. All other cases 
showed a large peritoneal m ass invading liver, pancreas and bowel. 
Mesenteric nodal involvement was common with less frequent 
involvement of paraaortic and mediastinal nodes. Involvement of 
pulmonary thymic and cervical nodes was occasionally apparent. 
Tum ours derived from case 2134 (anaplastic large cell lymphoma} 
showed splenic and gastrointestinal mucosal involvement which was not 
detectable in other tumours.
4 .3 .3 . R esults o f analysis o f transplanted HD tum ours
The results of analysis of transplantation of individual HD tum our cell 
suspensions are listed in Tables IV.III. to IV.VII. A summ ary of the 
results obtained is given in section 4.3.4.
Case 1371
Table IV.in. Results of case 1371 (LPHD)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ifi-ICC Ig-PCR
original -ve -ve -ve -ve NP -ve -ve
1st pass +ve +ve +ve NP NP AX R
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=not performed; R=rearrangement; pass=passage.
The RS cells of case 1371 showed CD20 and CD 15 positivity. The 
tum our was EBV-negative by LMP-1 and EBNA-2 immunostaining and 
EBER in situ  hybridisation and in addition, EBV was not demonstrable 
by Southern blot analysis with the BamHI-W probe. No detectable IgH 
gene rearrangem ent was present in DNA from this original material. In 
contrast the passaged tum our was EBV-positive as determined by LMP- 
1, EBER and EBNA-2 results. A clonal IgH gene rearrangem ent was 
detectable by PCR, and both Ig expression and secretion were evident in 
the passaged tumour.
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C ase 1145
Table IV.IV. Results of case 1 145  (LPHD)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve NP -ve -ve
1st pass +ve +ve +ve NS NP Gx(MA) R
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=not performed; NS=not satisfactory; R=rearrangement; 
pass= passage. Immunoglobulins in parentheses indicate the presence of minor 
populations.
RS cells from case 1145 were CD20 positive. EBV was not detectable by 
immunostaining or Southern blot analysis nor was there a 
rearrangem ent of the IgH gene demonstrable by PCR in the original 
tum our sample. The passaged tum our was shown to be EBV-positive by 
immunostaining and in situ hybridisation. An IgH gene rearrangem ent 
was demonstrable on PCR analysis and immunoglobulin expression and 
secretion were demonstrable. Passaged tum our material was diploid.
Case 2593
Table IV.V, Results of case 2593 (LPHD)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve -ve -ve -ve
1st pass(a) +ve +ve +ve +ve NP MGA, R
1st pass(b) +ve +ve +ve +ve NP MGxX R
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=Not performed; R=rearrangement; pass=passage.
RS cells in case 2593 were CD20 positive. Similar to cases 1371 and 
1145, the original tum our was EBV negative and no IgH gene 
rearrangem ent was demonstrable by PCR. Both tum ours arising in the 
SCID mice were EBV-positive by Southern blot analysis (Fig 4.1.), 
immunostaining and in situ  hybridisation and contained IgH gene 
rearrangem ents as detected by the PCR technique. Immunoglobulin 
secretion and expression were demonstrable in both passaged tum ours.
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Fig 4 .1 . Southern blot analysis of case 2 5 9 3  following 
restriction endonuclease digestion of sample DNA with Bam HI 
enzyme. DNA was hybridised with an EBV Bam HI-W specific 
probe. EBV-positive samples are identified by the presence of 
a 3 kb band as shown at the right hand side of the figure.
M= radioactive marker; T= original tumour sample; (a) & (b) 
denote SCID mouse tumours; P= placental control; +ve= EBV- 
infected B95-8 DNA.
F i g  4 . 1 .  E B V  S o u t h e r n  b l o t  a n a l y s i s  o f  c a s e  2 5 9 3
T (a) (b) P +ve
• •  • 3 Kb
Original tu m o u r  from case 2593 is EBV-negative an d  
both  SCID tu m o u rs  are EBV-positive a s  indicated by 
the 3 Kb band.
Both SCID mouse tum ours were diploid. The IgH gene rearrangem ents 
detected in the mice were of different sizes, as shown in Fig 4.2.
Case 2507
Table IV.VI. Results of case 2507 (NSHD)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve NP -ve -ve
1st pass +ve +ve +ve +ve NP GA. (Mx) R
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=Not performed; R=rearrangement; pass=passage. 
Immunoglobulins in parentheses indicate the presence of a minor population.
Both CD 15 and CD30 were expressed by the RS cells in case 2507. EBV 
was not detectable in original tum our material by any of the above 
methods nor was a rearrangement of the IgH gene observed by PCR. The 
passaged tum our was positive for EBV by immunostaining, in situ 
hybridisation and Southern blot analysis. A clonal IgH gene 
rearrangem ent was present in the SCID tum our which also showed 
immunoglobulin expression and secretion. The passaged tum our was 
diploid.
Case 1373
Table IV.VII. Results of case 1373 (MCHD)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original +ve +ve -ve +ve clonal -ve -ve
1st pass +ve +ve +ve +ve oligo Mx (GX) R
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; R=rearrangement; pass=passage; Immunoglobulins in 
parentheses indicate the presence of a minor population.
EBV was detectable in the original tum our material from case 1373 by 
LMP, EBER and Southern blot analysis. Examination of the terminal 
repeat sequences of this tum our revealed a clonal EBV-infected cell 
population. An IgH gene rearrangement was not detected in this sample
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Fig 4 .2 . PCR products from case 2 5 9 3  following amplification 
with IgH PCR primers as shown in Table IV.I. Products were 
electrophoresed on polyacrylamide gels and ethidium bromide- 
stained. A size reference is given in bp at the left hand side of 
the figure.
M= <j>X 174/H ae III marker; (a) & (b)= SCID mouse tumours; 
T= original tumour material.
Fig 4.2. IgH PCR analysis of case 2593
M (a) (b) T
118  b p  >
72  bp
N o  IgH  g e n e  r e a r r a n g e m e n t  w a s  d e t e c t a b l e  i n  
o r ig in a l  t u m o u r  m a te r ia l .  B o t h  S C ID  t u m o u r s  (a) &  
(b) h a v e  d e t e c t a b le  r e a r r a n g e m e n t s  w h i c h  d if f e r  in
s iz e .
by PCR analysis. The passaged tum our was also EBV-positive as shown 
in Table IV.VII. and hyridisation with a terminal repeat sequence probe 
was performed. The EBV in the SCID mouse tum our was oligoclonal in 
nature in contrast to the clonal EBV genomes in the original tumour. 
The dominant clonal EBV genome detectable in original tum our tissue 
differed in size to tha t of the passaged tum our. Passaged tum our was 
diploid.
4 .3 .4 . Summary o f the findings from transplanted HD tumour 
tissu e
As described in Tables IV.III.-IV.VII. tum ours developed in SCID mice 
following injection of tum our cells from 5 cases of HD. All of the 
tum ours were high grade, large cell, B-cell lymphomas. As well as 
expressing B-cell antigens (CD 19, CD20 and CD22) all cases expressed 
CD23 and CD43 with weak CD30 expression. All cases showed Ig 
expression usually with a marked predominance of a clone expressing a 
single heavy and light chain which was also present as secreted Ig in 
mouse serum. All of the SCID tum ours had clonal IgH gene 
rearrangem ents, however none of the original HD tum ours contained 
detectable rearrangements utilising the PCR technique. All 
rearrangem ents detectable by PCR were of differing sizes thus allowing 
distinction between the clones. In each of the tum ours arising in the 
SCID mice expression of LMP-1, EBER and EBNA-2 was evident. Case 
1373 (MCHD) was the only case in which LMP-1 and EBER expression 
were shown in the RS cells in the original biopsy material. In this case, 
clonal EBV was demonstrable by Southern blot analysis in the original 
sample however EBV in the passaged tum our was oligoclonal with no 
resemblance to the original clone. All of the tum ours arising in SCID 
mice following transplantation of HD material were diploid.
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4 .3 .5 . R esu lts o f  an a lysis o f  tran sp lan ted  NHL tum ou rs
The results obtained following the injection of cell suspensions from NHL 
cases into SCID mice are detailed in Tables IV. Vm.-IV.XIII. A summary 
of the results obtained is given in section 4.3.6.
Case 1372
Table IV.v m . Results of case 1372 (CB lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon IC-ICC Ig-PCR
original # -ve -ve -ve NP NP Mx R*
1st pass (a) -ve -ve -ve -ve -ve Mx R*
2nd pass(b-d) -ve -ve -ve -ve -ve Mx R*
3rd pass (e-h) -ve -ve -ve -ve -ve Mx R*
4th pass (i-1) -ve -ve -ve -ve -ve Mx R*
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; R*=identical size of rearrangement in original tissue and 
passaged tumour material; NP=not performed; # = No DNA available for Southern blot 
analysis; pass= passage.
Original material and passaged tum our tissue from case 1372 were 
consistently negative for the presence of EBV by the methods shown in 
Table IV.VIII. The tum our was successfully passaged 4 times with an 
identical IgH gene rearrangem ent present in the original tum our tissue 
and all subsequent passages. In addition identical Ig expression was 
detectable in both the original material and all passaged tissue, however 
no Ig secretion was evident. Although only one rearrangem ent was 
present in this case as detected by PCR, 3 rearrangem ents were 
detectable by Southern blot analysis in SCID tum ours with the IgH gene 
J H probe (Fig 4.3.(A)). The original tum our and SCID derived tum our 
also contained a bcl-2 translocation as detected by PCR; this 
translocation was detectable by Southern blot analysis in the SCID mice 
tum ours on hybridisation with a bcl-2 fragment probe. Fig 4.3. (B) 
illustrates the presence of the bcl-2 translocation in passaged tum our 
m aterial by Southern blot analysis.
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Fig 4 .3 . Southern blot analysis of case 1372 following 
restriction endonuclease digestion of sample DNA with Hind III 
enzyme. Fig A shows the result obtained following 
hybridisation of the DNA with an IgH joining region probe. Fig 
B illustrates the result obtained following hybridisation with a 
bcl-2 gene fragment probe.
R= gene rearrangement; G= germline; P= placental control; 1, 
2, 3 and 4= representative samples of each of four passages of 
SCID mouse tumours.
F i g  4 . 3 .  S o u t h e r n  b l o t  a n a l y s e s  o f  c a s e  1 3 7 2
A
1 2 3 4 P
Three IgH gene re a rra n g e m e n ts  were detec tab le  in 
ea ch  of fou r p a s s a g e s  of th e  SCID tu m o u r s  from 
case 1372.
B
R
A bcl-2 gene re a rra n g em en t w as de tec ted  in each 
of four p a s sa g e s  of the  SCID tu m o u rs  from case 
1372.
C ase 2592
Table IV.IX. Results of case 2592 (CB lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve NP Mx R*
1st pass -ve -ve -ve NP NP Mx R*
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; R*=identical gene rearrangement present in original 
tumour and passaged biopsy specimens; NP=not performed; pass=passage.
Both original material and SCID derived tum our material were negative 
for the presence of EBV by the above procedures. Both tum ours had 
detectable IgH gene rearrangements of the same size as detected by PCR 
analysis, and exhibited identical Ig expression. Secretion of Ig was not 
apparent. Passaged tum our material was tetraploid.
Case 2594
Table IV.X. Results of case 2594 (CB lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve NS NP R*
1st pass -ve -ve -ve -ve NP G k R*
LMP=LMP-1 staining; BW=Bam H-I-W analysis; Cion=clonality analysis; 
ICC=Immunocytochemistry; R*=identical size of immunoglobulin gene rearrangement 
in original tissue and passaged tumour material; NP=not performed; NS=not 
satisfactory; pass=passage.
Original tissue and passaged tum our material were EBV-negative. Both 
tum ours contained IgH gene rearrangem ents of the same size as 
detected by PCR analysis and showed similar Ig expression. No Ig 
secretion was detectable. Passaged tum our tissue was tetraploid.
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C ase 2 6 2 0
Table IV.XI. Results of case 2 6 2 0  (Immunoblastic lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve NP Gx -ve
1st pass -ve -ve -ve -ve NP Gx -ve
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=not performed; pass=passage.
In case 2620 both original material and passage tissue were EBV- 
negative. No IgH gene rearrangem ent was detectable in either tum our 
using PCR methodology. No DNA was available for assessm ent and 
comparison of IgH gene rearrangem ents by Southern blot analysis. Both 
tum ours showed similar Ig expression and in the passaged tum our small 
am ounts of secreted hum an IgG were detectable in mouse serum. The 
passaged tum our was aneuploid.
Case 2506
Table IV.XII. Results of case 2506 (CB/Cc- follicular lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original -ve -ve -ve -ve NP Gx -ve
1st pass +ve +ve +ve +ve NP GX(MAx) +ve
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; NP=not performed; pass=passage. Immunoglobulins in 
parentheses indicate the presence of a minor population.
The original tum our material from case 2506 was EBV-negative however 
passaged tum our material was EBV-positive by immunostaining, in situ 
hybridisation and Southern blot analysis. No detectable IgH gene 
rearrangem ent was present in the original material, although a clonal 
IgH gene rearrangem ent was demonstrable in the passaged tum our by 
PCR. The Ig expressed in the original tum our differed from tha t of the 
passaged material which also showed Ig secretion. Passaged tum our 
material was diploid.
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Case 213 4
Table IV.XIII. Results of case 2134 (LC anaplastic lymphoma)
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original (1) <.01% +ve -ve +ve Clonal 1 A -ve
1st pass (la) +ve +ve +ve +ve D* GX (M) R1
1st pass (lb) +ve +ve +ve +ve D* MX R2
1st pass (lc) +ve +ve +ve +ve D* Gx R3
1st pass (Id) +ve +ve +ve +ve D* MxX (GA) -ve
Biopsy LMP EBER EBNA-2 EBV-BW EBV-Clon Ig-ICC Ig-PCR
original (2) -ve +ve -ve +ve Clonal 1 A -ve
1st pass (2a) +ve +ve -ve +ve Dl* A -ve
1st pass (2b) +ve +ve +ve +ve Dl* A -ve
1st pass (2c) -ve +ve -ve +ve Dl* A -ve
1st pass (2d) +ve +ve +ve +ve D* A(M) R4
1st pass (2e) -ve +ve -ve +ve NS A -ve
LMP=LMP-1 staining; BW=Bam HI-W analysis; Clon=clonality analysis; 
ICC=Immunocytochemistry; D*=Dominant clone with numerous linear or other 
episomal forms; Dl*=identical size of dominant clone to original tumour specimens; 
Rl-R4=IgH gene rearrangements detected by PCR of variable size. Immunoglobulins in 
parentheses indicate the presence of a minor population; pass=passage.
EBV was demonstrable in original tum our material from biopsy (1) by 
EBER in situ  hybridisation and Southern blot analysis. Investigation of 
the EBV terminal repeat sequences in this sample revealed a clonal EBV 
pattern. An IgH gene rearrangem ent was not detected by PCR and 
sufficient DNA was not available for Southern blot analysis of the IgH 
gene, however, IgA was expressed in original tum our material. Injection 
of tum our material from biopsy (1) gave rise to tum ours in 4 SCID mice. 
The presence of EBV was evident in all samples by Southern blot 
analysis (Fig 4.4.), EBER in situ  hybridisation and LMP-1 and EBNA-2 
immunostaining. On hybridisation with an  EBV terminal repeat 
sequence probe, a dominant EBV genome was present in all passaged 
tum ours with a ladder of other bands indicating the presence of 
additional episomes or linear forms. In 2 samples (lc and Id) the 
dom inant clone appeared similar in size to tha t of the original biopsy. 
Three SCID mice tum ours contained clonal IgH gene rearrangem ents of 
different sizes when PCR analysis was performed. An IgH gene
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Fig 4 .4 . Southern blot analysis of case 2134(1) following 
restriction endonuclease digestion with Bam HI enzyme. DNA 
was hybridised with a 3 kb EBV Bam Hl-W probe.
1= original tumour sample; 1(a) - 1(d) = passaged SCID mouse 
tumours; P= placental control; +ve= EBV-infected B95-8 DNA.
Fig  4 .4 . EBV S o u th e rn  b lo t an a ly s is  o f  ca se  n o  2134(1)
1 1(a) 1(b) 1(c) 1(d) P +ve
Original tum our 2134(1) and passaged SCID tum ours 
are EBV- positive as indicated by the 3 Kb band.
rearrangem ent was detectable in the fourth SCID tum our by Southern 
blot analysis which differed in size to tha t of original tum our tissue. 
Both Ig expression and secretion were detected in these tum ours 
however the Ig type was different in each of the cases and differed from 
th a t of the original tumour. Fig 4.5. illustrates the allelic pattern 
observed in original and SCID mouse tum our material following 
amplification with the D1S80 forensic kit as discussed in section 4.2.4.5.
EBV was also detected in original biopsy (2) from this case by EBER in 
situ  and Southern blot analyses. Assessment of the EBV clonality 
showed the presence of an  identical clonal EBV genome to tha t in biopsy 
(1). No IgH gene rearrangem ent was detectable in this sample by PCR 
although on Southern blot analysis IgH gene rearrangem ents were 
present. As in tum our (1), IgA expression was detected in original 
tum our material from biopsy (2). Five tum ours developed in SCID mice 
following injection of original tum our cell suspension. All tum ours were 
EBV-positive. Following hybridisation with an  EBV terminal repeat 
sequence probe, 3 tum ours (2a, 2b and 2c) had a demonstrable EBV 
clonal genome which was identical in size to tha t of the original tum our 
sample (Fig 4.6.). IgH gene rearrangem ents were not detectable in these 
samples by PCR, although on Southern blot analysis, IgH gene 
rearrangem ents identical to that of original tum our material were 
present in cases 2a, 2b and 2c. IgA expression was detectable in these 
SCID tum ours which was identical to tha t expressed in original tum our 
material.
Biopsy 2d was EBV-positive however the dominant clone detectable on 
analysis of the terminal repeat sequences differed from tha t of original 
biopsy material. An IgH gene rearrangement was detectable in this 
sample by PCR and examination by Southern blot analysis showed that 
the rearrangem ents present also differed from original material. Both Ig 
expression and secretion were detectable in sample 2d and differed from 
tha t of original tum our specimen.
SCID tum our 2e showed EBER and not LMP-1 and EBNA-2 expression 
which was the same EBV gene expression pattern to tha t detected in the 
original biopsy material. No comparison of the terminal repeat sequence 
of the EBV genomes of this SCID tum our could be made as the DNA
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Fig 4 .5 . Ethidium bromide-stained PCR products following 
amplification with the D1S80 forensic typing kit.
M= (J)X 174/H ae III marker; 1= original tumour 2134(1); 1(a)- 
l(c)= passaged SCID mouse tumours; W= negative water 
control.
F ig  4 .5 . D 1 S 8 0  fo re n s ic  ty p in g  o f  c a s e  n o  2 1 3 4 (1 )
The symbol * illustrates the two bands common to original and 
passaged  tu m o u r sam ples ind icating  th a t the  SCID tu m o u rs  
are derived from sam ple 2134(1).
Fig 4 .6 . Southern blot analysis of case 2134(2) following 
restriction endonuclease digestion with Bam HI enzyme. DNA 
was hybridised with an EBV terminal repeat sequence probe 
(Terminal 1).
M= radioactive marker; 2= original tumour 2134(2); 2(a)-2(e)= 
SCID mouse tumours; P= placental control; +ve= EBV-infected 
B958 DNA.
Fig 4 .6 . EBV term inal repeat sequence analysis o f  case 2134(2)
M 2 2(a)2(b)2(c)2(d)2(e) P +ve
DNA from original tumour sample 2134(2) and SCID tumours 
2(a), 2(b) and 2(c) contain a dominant EBV episom e of 
identical size on Southern blot analysis. Sample 2(d) contains 
a dominant EBV episome which differs from original tumour 
material. Sample 2(e) is degraded.
sample became degraded during the course of the study. Similar to 
original tum our material, this sample had no detectable IgH gene 
rearrangem ents by PCR. A comparison of Southern blot analysis of the 
IgH gene was not possible however this tum our also showed similar Ig 
expression to the original sample.
4 .3 .6 . Summary o f the findings from transplanted NHL tumour 
tissu e
Three cases of centroblastic lymphoma and one case of immunoblastic 
lymphoma produced tum ours in SCID mice. These showed almost 
identical morphology and immunophenotype to the original tum ours. In 
addition, the passaged tum ours showed identical patterns of Ig 
expression and Ig gene rearrangement to the original biopsy specimens. 
These cases showed no detectable Ig secretion in mouse serum, except 
case 2620, an  immunoblastic lymphoma, which showed small am ounts 
of secreted hum an IgG. All of the tum ours were tetraploid or aneuploid, 
and EBV was not detectable in any of the tum our samples.
One case of follicular lymphoma also produced a high grade lymphoma 
in a SCID mouse. Histologically this was a B-cell immunoblastic 
lymphoma which showed a different pattern of Ig expression and gene 
rearrangem ent to that of the original material. The secretion of hum an 
Ig in mouse serum  was also detected in the SCID mouse from this case. 
This tum our was diploid, EBV was detectable by Southern blot analysis 
and EBV gene products were expressed.
Two biopsies from a case of large cell anaplastic lymphoma were 
transplanted into SCID mice. All mice injected with tum our cell 
suspensions developed lymphomas. All four tum ours derived from the 
first biopsy and one of five tum ours derived from the second biopsy were 
CD20-positive B-cell immunoblastic lymphomas expressing LMP-1, 
EBNA-2 and EBER. These tum ours were diploid and all showed 
different patterns of Ig expression, and different IgH gene 
rearrangem ents to the original biopsy specimen. In contrast, four of the 
tum ours derived from the second biopsy were CD20-negative large cell 
lymphomas containing multinucleated cells, similar to those in the
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original biopsy. All were EBV-positive and in two of these tum ours only 
EBER and not EBNA-2 and LMP-1 was expressed which was identical to 
the pattern seen in the original material. In one of these tum ours a 
small num ber of LMP-1 positive cells were detected and the other 
tum our showed foci of LMP-1 and EBNA-2 positive cells. These tum ours 
were tetraploid and contained an  identical IgH gene rearrangem ent to 
tha t of the original material and identical IgA expression. One DNA 
sample was degraded and therefore Southern blot analysis of the IgH 
gene was not possible.
4 .4 . DISCUSSION
Following transplantation of tum our material from HD and NHL into 
SCID mice, three types of lymphoproliferative disorder were observed:
1. EBV-negative lymphomas derived from high grade NHLs. These 
tum ours were aneuploid and showed phenotypic and genotypic 
findings which were identical to those of the original tum our 
specimens. In one case (1372) the tum our cells were successfully 
passaged four times.
2. EBV-positive lymphomas including those derived from a case of large 
cell anaplastic lymphoma. These tum ours had phenotypic and 
genotypic findings which related to those found in original tum our 
material. These tum ours showed EBER expression and minimal, or 
no, LMP-1 and EBNA-2. This pattern of EBV gene expression is tha t 
described in type I or type II latency as found in HD and in cases of 
large cell anaplastic lymphoma (Rowe et a t , 1992; Hamilton-Dutoit et 
a t,  1993).
3. EBV-induced lymphoproliferations derived from HD biopsies, one 
case of follicular lymphoma and some tum ours from the large cell 
anaplastic lymphoma case. These tum ours were diploid and showed 
clonal or oligoclonal IgH gene rearrangem ents with expression of 
EBER, LMP-1 and EBNA-2. This pattern of EBV expression 
corresponds to type III latency which is similar to tha t seen in LCLs 
and cases of lymphoma produced in SCID mice following injection of 
normal EBV-infected lymphocytes (Rowe et a t , 1992). Therefore, in 
contrast to the second category of EBV-positive tum ours, these 
tum ours are unlikely to have arisen from tum our cells within original 
tum our material. A plausible explanation is tha t the EBV-positive 
tum ours within these SCID mice arose from normal B-cells within the 
tum our biopsy.
The results from this study clearly show that in some cases tum our 
material from NHL cases can be successfully propagated using the SCID 
mouse model. A proportion of these tum ours were EBV-negative and 
therefore the virus could not have played a role in the development of the
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SCID mouse tum ours. Four EBV-positive tum ours passaged from the 
case of large cell anaplastic lymphoma bore a  direct relationship to 
original tum our material. SCID mice would therefore appear to be a 
useful tool for investigation of NHL tum our tissue.
In contrast to the above, transplantation of the RS cells contained within 
HD material into SCID mice appeared unsuccessful. In our experiments 
transplantation of HD tum our tissue into this model gave rise to EBV- 
driven lymphoproliferations. The only previous report of transplantation 
of HD into SCID mice was by Kapp et a l,  (1993) in which 3 /1 3  cases 
developed B-cell lymphoma following transplantation of tum our cell 
fragments. All 3 SCID mouse tum ours were EBV-positive. In the latter 
study 3 categories were defined; (1) lymphoproliferative disease 
containing medium and large cell immunoblasts with some plasmacytoid 
cells, (2) lymphomas resembling anaplastic large cell lymphomas and (3) 
HD-like lesions containing RS-like cells surrounded by murine 
macrophages. The lymphoproliferative disease seen by this group 
corresponds closely to the polymorphous immunoblastic proliferations 
described in our study, however, no anaplastic large cell lymphomas or 
HD-like lesions were observed by us following injection of HD tum our 
suspensions into SCID mice.
It is well established that normal blood or tonsillar B-cells from 
individuals infected with EBV will, in most cases, produce B-cell 
lymphoproliferation following inoculation into SCID mice (Rowe et a l, 
1991; Nakamine et aL, 1991, 1993). These cases appear to have a 
similar m ature B-cell phenotype and EBV expression pattern to that 
seen by ourselves following transplantation of HD tum our material. It 
therefore appears unlikely tha t the HD-like tum ours described by Kapp 
et a l,  (1993) were derived from neoplastic cells in the original tum our 
material. A strong possibility is that these tum ours were derived from 
EBV infection of normal B-cells within the reactive component of original 
tum our material. This is supported in our study by the normal diploid 
DNA content of these tumours.
A clear example of EBV lymphoproliferation arising from EBV-infected 
bystander cells was shown in HD case 1373 within this study. Original 
tum our material was shown to be EBV-positive, containing a clonal EBV
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genome. In contrast, although the SCID mouse tum our was also EBV- 
positive, it contained oligoclonal EBV which differed in genome size from 
tha t of the original tumour. This highlights the im portant use of EBV as 
a clonal marker when analysing tissue samples. Unfortunately no 
detectable IgH gene rearrangem ents were present in original material 
from HD tissue samples and therefore could not be used for comparisons 
of clonality.
In conclusion, SCID mice do not seem to be a satisfactory model for the 
study of the neoplastic cells of HD a t present. Tumours arising in SCID 
mice following injection of HD tum our cell suspensions appear to be 
EBV-driven lymphoproliferations. Further studies are required to resolve 
this issue using larger num bers of HD cases and clonotypic markers, 
such as those used in this study or cytogenetic markers, for comparison 
of original tum our tissue and passaged material. Perhaps in further 
studies the SCID mouse will prove to be an unsatisfactory model for the 
growth of HD tum our material due to the lack of a functional immune 
system. Cell-cell or cytokine interactions may be required for the growth 
of neoplastic cells in HD, however these functions are absent in SCID 
mice.
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CHAPTER 5
A DEGENERATE PCR STRATEGY FOR THE DETECTION OF
HERPESVIRUS SEQUENCES
5 .1 . INTRODUCTION
As previously described, epidemiological studies suggest an  infectious 
aetiology in the young adult peak of HD in developed countries. Clonal 
EBV genomes have been detected, and localised to the RS cells, in 
approximately 40% of HD patients. EBV is associated with the 
paediatric and older adult cases of HD and is more frequently found in 
association with the HDMC as compared to the HDNS subtype. Young 
adult cases particularly of the HDNS subtype are non EBV-associated. 
It is within this group tha t strong evidence for an  infectious aetiology 
exists. The relatively small num bers of malignant cells in the HD 
tum our m ass have hampered research into both the characterisation of 
the RS cell and the search for novel infectious agents.
The primary aim of this study was to devise a PCR strategy to investigate 
whether known, or as yet uncharacterised herpesviruses, are present in 
the non EBV-associated HD cases, in particular young adult cases. A 
PCR suitable for this purpose m ust have the ability to detect herpesvirus 
sequences present a t low copy num ber within the RS cells. To fulfil 
these requirements, the PCR m ust be sensitive enough to detect one 
viral genome present in 1% of the cells in a tum our mass. Since several 
herpesviruses may be present within a HD sample, either within the RS 
cell or the reactive infiltrate, a PCR capable of distinguishing different 
viruses is advantageous. Such a PCR would provide a useful tool not 
only in the search for herpesvirus sequences in HD, but also in other 
clinical conditions where viral involvement is suspected.
5.1.1. Degenerate primers
Each of the amino acids in a given protein is encoded by a  3 nucleotide 
combination termed a codon. Many amino acids have more than  one 
codon and some such as leucine can be encoded by 6 different codons. 
Degenerate primers are a mixture of oligonucleotide sequences varying 
in base composition bu t with the same num ber of bases. In a PCR 
reaction, such primers may be substituted for primers of defined 
sequence to give specific gene amplification products. Degenerate
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primers can be used when the amino acid sequence, b u t not the 
nucleotide sequence, is available for a  particular protein.
Degenerate primers have been used successfully for the detection and 
cloning of a num ber of different genes e.g. the urate oxidase gene (Lee et 
a t,  1988) and the diabetes associated peptide (Girgis et aL, 1988). In 
both these examples, the sequence of the oligonucleotide m ixtures was 
derived from an  amino acid sequence where only a limited portion of the 
protein sequence was available.
Alternatively degenerate primers may be used when conserved 
nucleotide or amino acid sequences are available for a known gene 
family. Using these conserved sequences, new or as yet uncharacterised 
sequences related to a particular gene can be investigated. Mammalian 
and avian members of the hepadnavirus family were detected 
simultaneously using degenerate primers based on conserved amino 
acid sequence regions of the viral reverse transcriptase gene (Mack & 
Sninsky, 1988). In addition, degenerate primers have been used as a 
screening tool in the investigation of the association between hum an 
papillomavirus (HPV) and hum an colonic cancer. Utilising th is strategy, 
McGregor et a l, (1993) confirmed the presence of HPV in a proportion of 
cases. A nested degenerate PCR, based on a relatively well conserved 
portion of the LI capsid protein gene of genital HPVs, has also been used 
(Williamson & Rybicki, 1991). The two stage PCR was used to detect the 
presence of HPV in 13 out of 16 biopsies. Seven of the amplified 
products were sequenced, and one proved to be a previously 
uncharacterised HPV type.
Common to all herpesviruses is a glycoprotein referred to as gB in HSV-1 
(section 1.3.2.). Utilising a degenerate PCR strategy, based on the 
sequences of two well-conserved pentapeptides of the gB or gB-like 
genes, Compton, (1990) isolated the gB gene of the feline herpesvirus 1 
(FHV-1). The amino acid sequences of the known herpesvirus gB 
sequences were aligned and regions of conservation scored. A 23 amino 
acid region was identified tha t contained a unique sequence flanked by 
conserved pentapeptides. A set of primers was m anufactured based on 
the preferred codon usage of serine and arginine (Aota et a l,  1988) but 
with both possible codons for tyrosine and glutamic acid. Restriction
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enzyme sites were added to the 5' end of each primer to facilitate cloning 
and also improve primer duplex stability as previously described (Mack 
& Sninsky, 1988). A product of the predicted size of 85 bp (69 bp from 
the coding region plus 16 bp from the 5' extensions) was obtained. 
Following PCR amplification, the PCR gene product was cloned and 
sequenced. Employing a similar approach to tha t of Compton (1990), we 
designed a PCR strategy for the detection of herpesvirus gB sequences in 
DNA samples from clinical material.
5 .2 . OPTIMISATION AND VALIDATION
5.2.1. M aterials
The sources of materials commonly used throughout this study are 
detailed in Table V.I. All other materials and their sources were as 
detailed in the text.
Table V.I. Sources of commonly used PCR materials
M aterials Sources
0.2 mL PCR tubes Perkin-Elmer (Applied Biosystems)
PCR reagents: All Perkin-Elmer (Applied Biosystems)
Amplitaq enzyme
Nucleotides
1.5 mM magnesium buffer
Primers Alta Bioscience
Metaphor agarose Flowgen
TaqStart antibody Clontech
Ampliwax beads Perkin-Elmer (Applied Biosystems)
Sterile water Gibco/BRL
All therm al cycling param eters were performed in a programmable heat 
block (Perkin-Elmer 9600, PCR machine) unless otherwise stated.
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5 .2 .2 . PRELIMINARY EXPERIMENTS
5.2 .2 .1 . Degenerate gB primers
In preliminary experiments degenerate PCR primers, identical to those 
described by Compton (1990), were m anufactured within the 
Department of Veterinary Pathology as described in section 2.5.1. The 
primers were titrated as described in section 2.5.3. using an  HSV-1 
template. On repeated occasions, with num erous different cycling 
param eters, no visible product was obtained following therm al cycling 
and polyacrylamide gel electrophoresis. EBV B95-8 DNA was used as 
template with the above primers and again no PCR product was 
detectable. Finally an  EHV-4 template was chosen, as the primers 
appeared to cover the codon usage for this particular virus, and visible 
product was detected. It was thus clear tha t these primers do not have 
the ability to amplify all known herpesviruses, a t least a t the template 
concentrations tested. We require a PCR reaction which has the ability 
to detect any herpesvirus, and not selected sequences, within a clinical 
DNA sample, and therefore designed new primer sets to cover all known 
herpesviruses.
5.2 .2 .2 . Primers containing inosine residues
Several experiments have suggested tha t inosine may be an  "inert" base 
(Ohtsuka et a l, 1985; Martin et a l , 1985). Primers containing inosine 
bases have been used successfully to amplify genomic fragments for the 
generation of DNA probes in situations where only the peptide sequence 
was available (Aarts et a l , 1991). Inosine is usually inserted a t base 
positions with 3- to 4-fold redundancy and therefore may be useful for 
the investigation of proteins with highly degenerate codons. The PCR 
strategy described in this chapter requires a  highly degenerate primer 
set. An inosine residue incorporated into primers a t a position 
containing a 4-fold degeneracy, would allow a reduction in the num ber 
of primers in the overall primer mixture.
A set of gB degenerate primers (section 5.2.2.1.) was m anufactured with 
inosine bases substituted at positions containing 4-fold redundancies.
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After repeated analysis no PCR product was detectable following gel 
electrophoresis and ethidium bromide-staining (section 2.5.6.). Inosine 
residues were therefore not used in future experiments.
5.2 .2 .3 . Primers derived from herpesvirus polymerase genes
A set of degenerate primers based on the EBV polymerase gene was 
m anufactured and tested using a strategy similar to tha t described by 
Teo et a l  (1991). They used degenerate primers based on conserved 
amino acid sequences of 5 hum an herpesvirus polymerase genes to 
isolate a DNA probe for the DNA polymerase gene of HHV-6. We 
m anufactured 3 primers, each with 16-fold degeneracy based on the 
EBV sequence. These primers were less degenerate than  the primers 
used for the isolation of the HHV-6 polymerase gene. Combinations of 
the primers were tested using B95-8 DNA as template. Although the 
assay did work, certain primer sets only did so following the addition of 
10% glycerol to the reaction. For our purposes a  strategy was required 
which would allow uniform reaction and cycling conditions. We 
therefore decided that a strategy using gB degenerate primers was 
preferable.
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5 .2 .3 . RATIONALE FOR PCR WITH DEGENERATE gB PRIMERS
The sequences of the well conserved regions, corresponding to the 
pentapeptides CYSRP and EGQLG, were aligned for the herpesvirus gB 
and gB gene homologues (Table V.IL).
Table V .n. Alignment of two conserved pentapeptide regions of 
herpesvirus gB sequences.
VIRUS N-terminal
pentapeptide
C-terminal
pentapeptide
Source
BHV-l CYSRP EGQLG Lawrence etaL , 1986.
BHV-2 CYSRP EGQLG Hammerschmidt etaL, 1988.
EBV CYSRP EGQLG Pellet etaL , 1985.
EHV-1 CYSRP EGQLG Whalley etaL , 1989.
EHV-4 CYSRP EGQLG Riggio etaL , 1988.
FHV-1 CYSRP EGQLG Spatz & Maes, 1993.
HCMV CYSRP YGQLG Cranage etaL , 1986.
HHV-6 g s CYNRP LGQLG Chou & Marousek, 1992.
HHV-6 Z29 CYNRP PGQLG Chou & Marousek, 1992.
HSV-1 CYSRP EGQLG Bzik etaL , 1984.
HSV-2 CYSRP EGQLG Bzik etaL , 1986.
ILTV CYTRP LGQLG Griffin, 1991.
MCMV CYSRP SGQLG Rapp etaL , 1992.
MDV CYSRP QGQLG Ross etaL , 1989.
PRV CYSRP EGQLG Robbins etaL , 1987.
SHV SA8 CYSRP EGQLG Borcher et aL, 1991.
VZV CYSRP EGQLG Keller etaL , 1986.
BHV-l, Bovine herpesvirus-1; BHV-2, Bovine herpesvirus-2; EBV, Epstein-Barr virus; 
EHV-1, Equine herpesvirus-1; EHV-4, Equine herpesvirus-4; FHV-1, Feline 
herpesvirus-1; HCMV, Human cytomegalovirus; HHV-6, Human herpesvirus-6; HSV-1, 
Herpes simplex virus-1; HSV-2, Herpes simplex virus-2; ILTV, Infectious 
laryngotracheitis virus; MCMV, Murine cytomegalovirus; MDV, Marek's disease virus; 
PRV, Pseudorabies virus; SHV SA8, Simian herpesvirus SA8; VZV, Varicella-zoster 
virus.
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The num ber of primers required to cover every possible codon usage of 
the aligned pentapeptides is 768 5’ primers and 4096 3’ primers. The 
amino acid codon usage of the pentapeptides is detailed in Tables V.III. 
and V.IV. From the outset it seemed likely tha t a single primer set, with 
this level of degeneracy, would not provide the necessary sensitivity. We 
therefore envisaged tha t multiple primer sets, each with more limited 
degeneracy, would be required.
An extensive set of experiments was performed to determine:
1. The maximum degeneracy that could be tolerated while maintaining 
the necessary sensitivity.
2. The optimal reaction and cycling conditions required.
3. A method of performing the assay which was economical in both time 
and expense.
These variables could not be considered independently and therefore, 
within many experiments, multiple comparisons were made. Since only 
one variable was changed in each comparison, many of the experiments 
appear large and complex.
The level of degeneracy that could be tolerated within the assay was 
assessed using an EBV viral template. An EBV template was also used 
to optimise cycling conditions and the sensitivity of the reaction before 
manufacturing the complete set of primers.
The rationales for choice of thermal cycling param eters can be conflicting 
and therefore various thermal cycling conditions were compared. 
Compton (1990) documented the importance of a low annealing 
tem perature in the initial rounds of amplification, to allow the coding 
sequence of the small primers to anneal to target DNA. In subsequent 
cycles the annealing temperature was raised since incorporation of the 
restriction enzyme sites into the primer duplex increased the stability of 
the reaction. In contrast, a rationale for a high initial annealing 
temperature, followed by a gradual decrease in annealing temperature, 
also exists. A high annealing tem perature in the initial cycles would 
allow specific priming to commence and a gradual decrease
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Table V.III. Nucleotides required for all possible codon usage of amino 
acids C Y S /N /T  R P
Conserved amino acid sequences
c Y S/N /T R P
T G T T A T T C T C G T C C
C C A G C A C
A A
G
A
G
2 2 2 4 4 2 4
Numbers shown indicate the degeneracy at particular base positions. The bases 
highlighted in bold show only a 3-fold degeneracy at that particular position, however, 
due to technical limitations, a 4-fold degeneracy was synthesised. Only 2 bases from 
the codon for amino acid P were included. Table V.in. illustrates that a total of 768 5' 
primers are required to cover all possible codon usage of the amino acids shown.
Table V.IV. Nucleotides required for all possible codon usage of amino 
acids E/Y /L/P/S/QGQLG
Conserved amino acid sequences
E /Y /L /P /S /Q G Q L G
T T G G T C A A T T T G G T
C C C G C C C
A A A A A
G G G G G
4 4 4 2 2 4 4
Numbers shown indicate the degeneracy required at the individual base positions. 
Table V.IV. illustrates that 4096 3’ primers are required to cover all possible codon 
usage of the amino acids shown.
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in tem perature would enable more primer sequences to be used as 
specific product builds up. In view of these considerations thermal 
cycling programs were set up with, A: a constant annealing temperature, 
B: a low initial annealing, followed by a higher tem perature and C: 
touchdown PCR, where annealing tem perature is gradually decreased 
over a specified num ber of cycles.
A large num ber of degenerate primers was required for the assay. For 
ease of handling and to minimise outlay a PCR operable in a  96-well 
format was desirable.
Numerous experiments were performed in order to assess the optimal 
primer concentrations and buffering conditions of the PCR assay. These 
experiments are not detailed in th is chapter however the optimal 
conditions are described in the experiments shown. The following 
sections describe the key experiments performed in the optimisation and 
streamlining of this assay. In addition, they describe the validation of 
the PCR for the detection of herpesvirus DNA sequences in DNA from 
clinical biopsy material.
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5 .2 .4 . EXPERIMENT 1
T oleration  o f  degeneracy
As discussed in section 5.2.3., 768 5’ and 4096 3' primers are required 
to cover all possible codon usage for the aligned pentapeptides. A set of 
degenerate primers would allow a reduction in the overall num ber of 
syntheses required. It appeared unlikely tha t a single set of highly 
degenerate primers would have sufficient sensitivity for our purposes. In 
order to assess the level of degeneracy tha t could realistically be 
tolerated in any individual reaction, an  EBV-based primer set was 
m anufactured. To save time and reduce cost a single EBV viral template 
was chosen for the following experiment.
5.2 .4 .1 . EBV gB degenerate primers
A set of primers was manufactured, as described in section 2.5.1., based 
on the well-conserved pentapeptide regions CYSRP and EGQLG from the 
known gB sequence of B95-8 EBV DNA. Primers with an  exact m atch to 
this sequence were manufactured, followed by primers containing 
varying am ounts of degeneracy up to 128-fold, as shown in Table V.V. 
Degenerate bases were avoided a t the 3* end of each primer. Five prime 
extensions containing restriction enzyme sites were added to each 
primer.
5.2 .4 .2 . PCR conditions
Primer sets 106/112, 105/111, 104/110, 103/109, 102/108 and 
102/107 (Table V.V.) were used a t a concentration of 1 pM in individual 
experiments to assess the level of degeneracy tha t could be tolerated. 
Ten fold, serial dilutions from 2 pg - 0.2 pg of B95-8 DNA in water, were 
used as template. PCR was performed as described in section 2.5.2. and 
products obtained following thermal cycling were electrophoresed and 
visualised as described in section 2.5.6.
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Table V.V. EBV gB degenerate primers.
5’ EBV gB primers conserved amino acid sequences
Primer Hind III C Y S R P Degeneracy
102 5'-TCA AAG CTT TGY TAY TCN CGN CC-3’ 64-fold
103 TGY TAY TCN CGC CC 16-fold
104 TGY TAY TCG CGC CC 4-fold
105 TGY TAC TCG CGC CC 2-fold
106 TGC TAC TCG CGC CC none
3' EBV gB primers conserved amino acid sequences
Primer EcoR I G L Q G E Degeneracy
107 5'-ATC GAA TTC NCC YAG YTG NCC NT-3’ 128-fold
108 NCC YAG YTG NCC CT 64-fold
109 NCC YAG YTG TCC CT 16-fold
110 NCC YAG CTG TCC CT 8-fold
111 NCC CAG CTG TCC CT 4-fold
112 GCC CAG CTG TCC CT none
5' and 31 primers all 23-mers. N=A+C+G+T, Y=C+T.
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5 .2 .4 .3 . R esu lts
Specific EBV gB product was detectable, following ethidium bromide 
staining, using 2 ng of B95-8 DNA and the 64-fold degenerate primer 
combination, 102/108. No PCR product was detectable on ethidium 
bromide-stained gels when the most degenerate primer combination, 
102/107 was used. In reactions containing the non-degenerate primer 
pair 106/112, PCR product was clearly demonstrable in the 0.2 pg 
dilution of B95-8 DNA.
The 64-fold degenerate primers 102 and 108 were chosen as candidates 
with which to perform further experiments to assess and optimise the 
sensitivity of the assay. Using 64-fold degenerate 5' and 3' primers the 
overall num ber of primers required was 12 and 64 respectively.
5.2.5. EXPERIMENT 2
Optimisation and sensitivity o f 64-fold degenerate EBV gB primers
5.2 .5 .1 . Template
To assess the sensitivity of the EBV gB degenerate primers 102/108 
(Table V.V.) a sample containing a known num ber of viral genomes was 
required. The EBV-infected cell line Raji has a stable EBV copy num ber 
of 46 per cell and was therefore chosen as template for these 
experiments. Forty nanograms of Raji DNA were diluted, using serial 
10-fold dilutions, to 0.4 ng of DNA in a  background of 2 pg of hum an 
placental DNA. Placental DNA was used as diluent rather than  water to 
mimic the effect of background DNA from cellular infiltrate which would 
be present when analysing HD DNA samples. The 0.4 ng dilution of Raji 
DNA in 2 pg of placental DNA is equivalent to 1 viral genome in 1% of the 
cells in a DNA sample derived from 3 x 105 cells. This was the 
sensitivity level required of the assay to allow detection of herpesviruses 
present within RS cells.
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5 .2 .5 .2 . H ot Start PCR
Ampliwax beads were employed in the PCR reactions to facilitate a Hot 
Start. Hot S tart PCR (Chou et a t, 1992) refers to the withholding of a 
critical reaction component until primers have attained a stringent 
annealing temperature. By performing a Hot S tart PCR, primer-dimer 
formation and non-specific priming of oligonucleotides prior to therm al 
cycling are reduced and therefore more specific priming is attained. This 
is of critical importance when a low copy num ber of target sequence is 
present in background DNA. An Ampliwax bead was placed in the 
reaction tube containing reaction components excluding the primers. 
The reactions were heated to 70°C for 10 m inutes to allow the wax bead 
to melt and cooled to room tem perature to form a seal. Primers in buffer 
were added on top of the wax layer before commencing therm al cycling.
5.2 .5 .3 . PCR conditions
PCR was carried out in a 50 pL volume containing 1 pM primers, 200 pM 
of each of the nucleotides (dGTP, dCTP, d ATP and dUTP), 1.5 mM 
magnesium buffer, and 1 U of Amplitaq DNA polymerase. Raji DNA 
dilutions as described in section 2.5.4.1. were used as template for the 
reactions. Hot S tarts were performed (section 5.2.4.2.J on all of the 
above reactions with a 30 pL upper mix volume and a 20 pL lower mix 
volume to allow optimal mixing of components, after initial denaturation. 
In addition, a positive control containing 40 ng of Raji DNA diluted in 
2 pg of hum an placental DNA as template and the less degenerate 
prim ers 103 and 109 was included in each of the experiments (section
5.2.3.1.). This control was included with and without the use of Hot 
S tart to allow comparison of the two methods.
5.2 .5 .4 . Thermal cycling conditions
Various thermal cycling conditions were tested in order to optimise the 
sensitivity of the assay. Prior to therm al cycling samples were denatured 
for 7 m inutes a t 94°C. Samples were ramped to 94°C over a 2 minute 
period and held at this tem perature for 10 seconds. This was followed
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by a 1 m inute ramp to the annealing tem perature and holding at 
tem perature for 30 seconds. In experiments 2C, 2D, 2G and  2H, 5 
cycles were performed a t 1 tem perature followed by 35 or 55 cycles a t a 
different temperature. Annealing tem peratures and cycle num bers were 
as  detailed in Table V.VI.
Table V.VI. Thermal cycling conditions used in experiments 2A - 2H
Experiment No Temp 1 Cycles Temp 2 Cycles
2A 550C 40
2B 370C 40
2C 55°C 5 370C 35
2D 370C 5 55°C 35
2E 55°C 60
2F 370C 60
2G 55°C 5 370C 55
2H 370C 5 550C 55
Following thermal cycling, reactions were extended a t 72°C for 7 
m inutes and finally brought to a tem perature of 6°C. Amplification 
products were analysed as described in section 2.5.6.
5.2 .5 .5 . Results
A PCR product of the expected size was clearly detectable on ethidium 
bromide-stained gels using 0.4 ng of Raji DNA and 60 cycles of 
amplification a t 55°C (experiment 2E). Following 40 cycles of 
amplification with annealing a t 55°C (experiment 2A), PCR product was 
only detectable down to the 4 ng dilution of Raji DNA. The increased 
cycle num ber in experiment 2E as compared to tha t of experiment 2A 
therefore increased the overall sensitivity of the reaction. In experiment 
2F, where 60 cycles of amplification using an annealing tem perature of 
37°C were performed, PCR product was also detectable in the 0.4 ng 
dilution of Raji DNA. However num erous other non-specific bands were 
also clearly visible, suggesting tha t the non-stringent annealing had 
allowed the amplification of non-target sequences. As was observed in
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experiment 2A, 40 cycles of amplification with an  annealing temperature 
of 37°C resulted in a reduced signal intensity when compared with 60 
cycles. Products from experiments 2B, 2C, 2D, 2G and 2H gave rise to 
weaker signals than  those described above. Experiment 2E was 
repeated to confirm the result, blotted (section 2.5.7) and hybridised 
(section 2.4.4.) with an EBV-specific internal gB probe. The signal 
obtained following gel electrophoresis confirmed the original result and 
hybridisation to the probe confirmed the authenticity of the product. In 
all experiments the Hot S tart PCR control with primers 103/109 gave an 
improved signal when compared to the non Hot S tart PCR.
In conclusion the assay conditions used in experiment 2E, with 60 
cycles of annealing a t 55°C, appears sensitive enough to detect 1 copy of 
a herpesvirus if present in 1% of the cell population in 2 pg of template 
DNA (Fig 5.1.). In addition, Hot S tart PCR improved overall sensitivity 
with the primer set 103/109.
5.2.6. EXPERIMENTS 
Optimisation o f PCR product detection
Hybridisation is not possible when searching for new or as yet 
uncharacterised viruses when there are no conserved sequences internal 
to the primer sequences. In this experiment various methods for the 
detection of PCR products were compared in an  attem pt to maximise the 
sensitivity of the assay.
5.2 .6 .1 . Captagene GCN4 kit
The Captagene GCN4 kit (British Bio-technology Products Ltd.) is an 
enzyme-linked assay for the detection of amplified target DNA. One 
primer within the reaction is biotinylated and the second incorporates a 
specific 12 bp recognition sequence for the dsDNA binding protein GCN4 
(Hinnebusch, 1984). Amplified dsDNA containing this specific 
recognition sequence is captured in the wells of a microtitre plate via 
solid-phase GCN4 fusion protein. The presence of amplified DNA can 
then be detected by a biotin-streptavidin peroxidase colorimetric
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Fig 5 .1 . Sensitivity of EBV gB degenerate primers. Template 
used was Raji DNA diluted in 2 pg of human placental DNA as 
shown below.
M= <j>X 174/Hae III marker; 1= 40 ng; 2= 4 ng; 3= 0.4 ng. 
Samples 1-3 all amplified with primers 102/108. +ve= 40 ng 
amplified with primers 103/109.
Fig 5 .1 . S e n s itiv ity  o f EBV gB d e g e n e ra te  p r im e rs
1 2  3 +ve M
EBV gB PCR product >
EBV gB PCR product is detectable in each of the sam ples using primers 
102 / 108 .
reaction. The technique has been used successfully for the detection of 
HIV sequences in acquired immunodeficiency syndrome (AIIDS) patients 
(Kemp et a t , 1990). Such a system would be an  ideal screening method 
for the detection of specific PCR product within th is assay without the 
need for gel electrophoresis. Samples which appeared positive using the 
GCN4 methodology could then be further analysed.
A set of EBV gB degenerate PCR primers containing the biotinylated 
group and GCN4 recognition sequence were synthesised. Following 
amplification the GCN4 kit was used for the detection of PCR product. A 
set of negative controls, containing placental DNA as template, were 
amplified under the same conditions as the test sample, to assess non­
specific background. Background within the negative controls was a t an 
unacceptably high level. This particular screening method was therefore 
considered inappropriate for the detection of gB PCR products.
5.2 .6 .2 . Fluorescein-labelled primers
Utilising an automated sequencer, products of PCRs may be analysed, 
without ethidium bromide staining, by scanning for a specific dye-label 
such as fluorescein. Manufacturers have claimed greater than  a  100- 
fold increase in detection sensitivity using this method compared to 
ethidium bromide-staining. Primers identical to 102/108 (section 
5.2.3.1.) were m anufactured with fluorescein groups on the 5' end of the 
primers. Test samples were amplified using fluoresceinated primers and 
analysed on an automated sequencer (Applied Biosystems). Results 
suggested tha t this would be the preferred method of analysis if the 
apparatus were available. The system enables accurate sizing and good 
visualisation of PCR product as shown in Fig 5.2.
A comparison was made between fluoresceinated and non- 
fluoresceinated primers to determine the effect of the fluorescein group 
on the sensitivity of the reaction. Ethidium bromide-stained gels were 
utilised in this analysis. In direct comparative experiments 
fluoresceinated primers performed inconsistently compared to the non- 
fluoresceinated primers. It was therefore decided to continue to use 
non-fluoresceinated primers in optimisation experiments.
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Fig 5 .2 . Analysis of fluoresceinated PCR products using the 
Applied Biosystems 373A automated sequencer. EBV-specific 
gB PCR product is 87 bp as shown in the figure.
Size m arkers: 43 bp , 94  bp, 109 bp, 116 bp, 172 bp  a n d  186 bp.
Fig 5 .2 . A utom ated analysis o f flu oresceinated  PCR products
peak
height
PCR product size in base pairs
*
,48 .5 8 .108 118 .128 .138 148 158 168 178 18888 ,98
2400,
2 0 0 0 ,
1600.
1200J
80 0 J
400.Z
* Indicates the expected size of EBV PCR product of 87 bp.
5 .2 .6 .3 . A n ested  PCR strategy  for th e  an a lysis o f  sm all sam p les
A nested PCR strategy was designed to increase template DNA from 
small samples for subsequent use in the gB PCR. One 5’ (A) and one 3’ 
(B) primer containing a string of Ns followed by 5 specific bases for the 5 
initial coding bases of the EBV primers 102 and 108 were manufactured 
(Table V.V.). The primer sequences are shown below.
5' Primers
A
102
5’- NNNN NNN 
5’-
TGYTA
TGYTA
-3’
Y TCN CGN CC-3'
3' Primers
B
108
5’- NNNN NNN 
5’-
NCC YA 
NCC YA
-3’
GYTG NCC CT-3'
Bases boxed in bold indicate the 5 bases specific for the 5' coding sequence of primers 
102 and 108 respectively. N=A+G+C+T, Y=C+T
We hypothesised that first round amplification with primers A and B 
may increase the specific gB template in the DNA sample due to the 
presence of the 5 bases homologous to the gB region of interest. To test 
th is hypothesis 0.4 ng of Raji DNA, diluted in water, were amplified with 
1 pM primers A and B in a standard PCR reaction (section 2.5.2.). 
Samples were denatured at 94°C for 5 minutes. Fifty cycles of 
amplification were then performed by denaturing samples a t 94°C 
followed by an annealing step a t 37°C for 1 minute. The products of the 
reaction were analysed as described in section 2.5.6.
No specific product was detectable on an  ethidium bromide-stained gel 
although, as expected, a smear was visible indicating the presence of 
products of variable size. The PCR product was diluted and a 1 /200 th  of 
the total PCR was used as template in a  further PCR reaction, with 2 pM 
primers 102/108 and all other components as previously stated (section
2.5.2.). A control sample containing 10 ng of EBV-infected Raji DNA was 
included. Samples were denatured at 94°C for 5 minutes, followed by 
60 cycles of amplification by denaturing at 94°C for 30 seconds and
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annealing a t 65°C for 1 minute. Products of the reaction were analysed 
as described in section 2.5.6.
Product of the expected size of 87 bp was clearly detectable on an 
ethidium bromide-stained gel from the control sample containing 10 ng 
of Raji DNA. In the test samples product of the correct size was also 
clearly detected (Fig.5.3.). Therefore sufficient template was generated in 
the first PCR reaction, utilising primers A and B and 0.4 ng of Raji DNA, 
to use in 200 individual PCR reactions for subsequent investigation with 
degenerate gB primers.
This particular strategy will be advantageous in situations were only 
limited am ounts of template DNA are available for the assay. Due to the 
large primer set used in the gB assay substantial am ounts of DNA are 
required as template. In a situation where purified RS cell populations 
are used for the assay only a small am ount of template DNA will be 
available. The use of the nested PCR strategy may increase specificity of 
the reaction and allow a decrease in the am ount of template required.
5.2.7. EXPERIMENT 4
Assessm ent o f primer purification methods
Before a large primer set was m anufactured a comparison of various 
primer purification methods was made using the EBV gB degenerate 
primers. Cartridge-purified, polyacrylamide gel electrophoresis (PAGE)- 
purified and non-purified primers were m anufactured with identical 
sequence to the primers 102 and 108 (section 5.2.3.1.). Primers were 
used a t a  concentration of 2 pM. One microgram of B95-8 DNA was 
used as template and all other components and cycling conditions were 
as described in section 2.5.2. Amplified products were analysed as 
described in section 2.5.6.
Cartridge-purified primers gave a distinctly stronger signal when 
compared to non-purified and PAGE-purified primer combinations. The 
results obtained in this experiment suggest tha t the use of cartridge- 
purified primers a t a concentration of 2 pM is optimal.
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Fig 5 .3 . Ethidium bromide-stained EBV gB PCR products 
following nested PCR analysis as described in section 5.2.6.3.
M= <j)X 174/Hae III marker; N= nested PCR product; +ve= 10 
ng Raji DNA.
Fig 5 .3 . N ested  PCR an a ly sis  o f EBV
EBV gB PCR p rod uct
EBV PCR product is clearly detectable following nested PCR analysis.
5 .2 .8 . EXPERIMENTS
C om parison o f  64-fold  and 128-fo ld  degenerate EBV gB prim ers
As we intend to search for as yet uncharacterised viruses our strategy 
has the need to cover every possible codon usage for the conserved 
amino acid sequences. If 64-fold degenerate 5' primers were used then 
12 5’ primers would be required. To minimise expense and increase 
practicality, a  comparison was made between the existing 64-fold and a 
new 128-fold degenerate 5' primer. A 128-fold degenerate 5' primer 
would reduce the num ber of 5’ primers required to only 6. Mismatch 
between target and primer are not well tolerated a t the 3’ end of the 
primer and therefore degeneracies were placed towards the 5’ end of the 
unique primer sequence. In addition, by keeping degeneracy away from 
the 3’ end of the primer different viruses may be distinguished by their 
preferential primer usage.
5.2 .8 .1 . Primer sets
A set of primers were m anufactured to allow comparisons of the 128-fold 
degenerate and 64-fold degenerate 5' primers to be assessed. The 
sequences of the 5’ primers used were as detailed below. The 3’ primer 
sequence was oligonucleotide 108 (Table V.V.).
64-fold degenerate 5’ primer - 5' TCA AAG CTT TGY TAY TCN CGN CC 3’ 
128-fold degenerate 5’ primer - 5’ TCA AAGCTT TGY TAY WNN CGC CC 3’ 
N=A+G+C+T, W=A+T and Y=C+T.
5.2 .8 .2  Cycling conditions
Reactions were performed in a 50 pL volume, containing 2 \iM of each 
primer with all other components as described in section 5.2.4.3. A Hot 
S tart was performed throughout (section 5.2.5.2.). Template used was 
Raji DNA dilutions in placental DNA as described in section 5.2.5.1. 
Various thermal cycling profiles were performed using each primer pair 
to assess the optimal primer set and preferred cycling conditions. 
Reactions were denatured for 5 m inutes at 94°C prior to therm al cycling.
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In each cycle the reactions were denatured a t 94°C for 30 seconds and 
then annealed as specified below. In experiments 5C and 5D a 
’’touchdown” PCR was performed in which the annealing temperature 
was dropped by 0.5°C per cycle for a specified num ber of cycles. In 
experiment 5C a touchdown strategy was used over the first 20 cycles 
followed by a constant tem perature of 55°C for 40 cycles. The 
touchdown was used to test whether stringent annealing in initial cycles 
would allow specific priming of product, followed by a lower annealing 
tem perature which would increase the sensitivity of the reaction. The 
tem peratures and cycle num bers were as detailed in  Table V.VH.
Table V.VII. Thermal cycling conditions used in experiments 5A-5D
Experiment Temp 1 At temp Cycles Temp 2 At temp Cycles
5A 55°C 1 min 60
5B 65°C 1 min 60
5C 65°C-55°C 1 min 20 55°C 1 min 40
5D 65°C- 1 min 60
Temperatures boxed in bold indicate touchdown thermal cycling.
5.2 .8 .3 . R esults and conclusions
Following acrylamide gel electrophoresis and ethidium bromide-staining 
of amplified PCR product (section 2.5.6.), the intensity of the EBV gB 
product using the primer sets and cycling conditions was compared. 
The touchdown PCR as described in experiment 5D did not give rise to 
detectable PCR product with either of the primer combinations. After 
analysis using conditions described in experiment 5C, PCR product was 
demonstrable in the 0.4 ng dilution of Raji DNA in the reaction 
containing the 128-fold degenerate 5’ primer but not in the reaction 
containing the 64-fold degenerate primer combination. Both primer sets 
resulted in detection of product in 0.4 ng of Raji DNA, using the cycling 
conditions described in 5A and 5B. The 65°C annealing tem perature 
gave rise to less non-specific amplification products than  55°C 
annealing and the intensity of specific bands was comparable.
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In conclusion, the 128-fold degenerate 5' primer gave rise to PCR 
product signal intensity which was comparable with tha t obtained using 
the 64-fold degenerate primer. By changing from a 64-fold, to a 128-fold 
degenerate 5’ primer, only 6 5' primers were required for the assay. The 
reduction in primer num ber brought the assay a step closer to a 96-well 
microtitre format. Although an annealing tem perature of 65°C gave a 
more specific result this was considered too stringent an  annealing 
tem perature to ensure detection of all possible viral sequences. A 
comparison of annealing tem peratures was performed in further 
experiments utilising different viral templates.
5.2.9. EXPERIMENT 6
Testing o f known viral tem plates with gB degenerate primers
In order to test whether the conditions optimised for the EBV template in 
previous sections would work equally well on other viral templates, the 
prim ers detailed in Table V.VIII. were manufactured.
Table V.VIII. Sequences of primers 6A-6H.
128-fold degenerate 5' primers all 23-mers
Virus 5f Primer Hind III
HSV-1 6A 5’ TCA AAG CTT TGY TAY WNN CGC CC 3’
PRV 6B TCA AAG CTT TGY TAY WNN CGC CC
VZV 6C TCA AAG CTT TGY TAY WNN CGT CC
EHV-4 6D TCA AAG CTT TGY TAY WNN CGC CC
64-fold degenerate 3’ primers all 23-mers
Virus 3’ Primer Eco R1
HSV-1 6E 5’ ATC GAA TTC NCC NAR YTG CCC CT 3’
PRV 6F ATC GAA TTC NCC NAR YTG GCC CT
VZV 6G ATC GAA TTC NCC NAR YTG GCC CT
EHV-4 6H ATC GAA TTC NCC NAR YTG GCC CT
N=A+G+C+T; R=A+G; W=A=T; Y=C+T.
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5 .2 .9 .1 . PCR com p on en ts and cy c lin g  co n d itio n s
The PCR reactions were performed in a 50 pL reaction containing 2 pM 
of each primer and 1.5 mM MgCl2  buffer. All other components were as 
described in section 5.2.5.3. One hundred nanogram s of HSV-1, PRV, 
VZV and EHV-4 viral DNA or plasmid were used as template for the 
specific primers. Samples were denatured for 5 m inutes a t 94°C prior to 
therm al cycling. The samples were then subjected to 60 cycles of 
amplification by denaturing the reactions for 30 seconds a t 94°C 
followed by annealing a t 55°C for 1 minutes. A 7 m inutes extension a t 
72°C was performed prior to cooling of the samples to 6°C.
In order to assess the effect of an increase in annealing tem perature on 
the reaction specificity the above reaction was performed with the 
exception tha t annealing was performed at 65°C. The results under 
both conditions were compared.
5.2 .9 .2 . Results
Following electrophoresis and ethidium bromide-staining (section 2.5.6.) 
amplified PCR product from each of the viral templates was detectable. 
On comparison of the 65°C and 55°C annealing tem peratures, primer- 
dimer formation appeared to be significantly reduced using the 65°C 
annealing temperature although overall signal was comparable. Results 
obtained from three of the viral templates following cycling a t 55°C are 
shown in Fig 5.4.
In conclusion although the 65°C annealing tem perature appeared to 
reduce primer dimer formation, it was decided to err on the side of 
caution and continue with a 55°C annealing tem perature which is less 
stringent.
97
F ig  5 .4 . Ethidium bromide-stained PCR products following 
PCR amplification of viral templates PRV, VZV and EHV-4.
M= <j>X 174/Hae III marker.
F ig  5 .4 . A m p lif ic a t io n  o f  v a r io u s  v i r a l  t e m p l a t e s
M PRV VZV EHV-4
11 8  bp — >  
72  b p — > gB PCR product
PCR product of the expected  size is  detectab le  from each  of the  
viral tem p lates.
5 .2 .1 0 . EXPERIMENT 7
C om parison o f  22-m er and 23-m er 3* prim ers
To further streamline the reaction and enable the use of a  96-well 
microtitre format the decision was made to reduce the 3’ primer by 1 
base from a 23-mer to a 22-mer. By removing the terminal base all 
possible codon usage for the pentapeptide would still be covered and yet 
only 16 3’ primers would be required. To test whether this reduced 
assay sensitivity, a comparison of an  EHV-4 specific 23-mer (Table 
V.Vm.) and a new 22-mer was made.
5.2 .10.1 . PCR components and cycling conditions
An EHV-4 template was used in the reaction with 10-fold dilutions of the 
DNA from 1 pg to 1 ng. Primers were used a t a concentration of 2 |~iM 
with all other reaction components as described previously (section
5.2.5.3.). Cycling conditions with a 55°C annealing step, described in 
Table V.VII. (experiment 5A) were used.
5.2.10.2 . Results and conclusions
Amplified PCR product was clearly detectable in all dilutions of template 
DNA used. The signal obtained on ethidium bromide-stained gels was 
comparable using the 3’ 22-mer or 23-mer. The results obtained from 
the 10 ng and 1 ng dilutions using the 22-mer and 23-mer primers are 
shown in Fig 5.5.
Therefore in the manufacturing of the final primer set all 3' prim ers were 
22 bases in length. This reduction in primer num ber allows the reaction 
to be performed in a 96-well microtitre format. This enables easier 
handling of the assay and also helps reduce overall cost.
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Fig 5 .5 . Comparison of 22-mer and 23-mer 3’ primers. 
Ethidium bromide-stained PCR products following PCR 
amplification as described in section 5.2.10.
M= (J)X 174/Hae III marker; 1= 10 ng EHV-4 DNA; 2= 1 ng 
EHV-4 DNA.
Fig 5 .5 . C om parison  o f 2 2 -m er and  2 3 -m er 3' p r im e rs
A 2 2 -m e r
M l 2
118  bp
72 bp — >
<—  EBV gB PCR p rod uct
B 2 3 -m e r
M l 2
118  bp >
EBV gB PCR p rod uct
Results obtained using the 22-mer and 23-mer are comparable.
5.2.11. EXPERIMENTS
Improved cycling conditions for the detection o f viral sequences
A complete set of primers was m anufactured for the final assay with six, 
128-fold degenerate 5’ primers (Table V.IX.) and sixteen, 64-fold 
degenerate 3’ primers (Table V.X.). Prior to utilising the primer 
combinations for the analysis of clinical DNA samples, further cycling 
conditions were compared in an attem pt to enhance both specificity and 
sensitivity of the reaction. The different primers used in the assay have 
a wide range of melting tem peratures and therefore thermal cycling 
conditions are critical as discussed in section 5.2.3. From previous 
experiments, a high initial annealing followed by a  reduction in 
tem perature did not appear to increase overall product yield (sections 
5.2.5.5. and 5.2.8.3.). A further optimisation experiment to test the 
effect of a low initial annealing step using known viral templates was 
performed.
Table V.IX. 128-fold degenerate 5' primers, all 23-mers
conserved amino-acid sequences
Prim er Hind HI C Y S /N /T R P
233 TCA AAG CTT TGY TAY WNN CGA CC
234 CGG CC
235 CGT CC
236 CGC CC
237 AGA CC
238 AGG CC
Table V.X. 64-fold degenerate 3’ primers, all 22-mers
conserved amino acid sequences
Prim er Eco R1 G L Q G E /Y /P /Q /L
201 ATC GAA TTC NCC NAR YTG ACC T
202 GCC T
203 TCC T
204 CCC T
205 ACC C
206 GCC C
207 TCC c
208 CCC c
209 ACC A
210 GCC A
211 TCC A
212 CCC A
213 ACC G
214 GCC G
215 TCC G
216 CCC C
N=A+G+C+T; W=A+T; Y=C+T.
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5 .2 .1 1 .1 . PCR com p on en ts and cyc lin g  co n d itio n s
One hundred nanograms and ten ng of both PRV and VZV DNA were 
used as template. Primers 206/236 and 206/235 were used a t a 
concentration of 2 pM for the PRV and VZV templates respectively. A 
Hot S tart PCR was performed for each sample with all other reaction 
components as in section 2.5.4.3.
Samples were denatured for 5 m inutes a t 94°C followed by 60 cycles of 
amplification. In the initial 3 cycles, reactions were denatured a t 94°C 
for 30 seconds then annealed a t 37°C for 1 minute followed by an 
increase in tem perature to 72°C over a 2 m inute period. Fifty seven 
further rounds of amplification were then performed as specified in Table 
V.XI.
Table V.XI. Thermal cycling conditions of Experiment 8
Experiment No Temp 1 At temp Temp 2 At temp Cycles
8A 940C 30 sec 65°C 1 min x57
8B 940C 30 sec 55°C lm in x57
5.2 .11 .2 . Results and conclusions
In experiment 8A with cycling a t 65°C the gB gene product signal was 
lost in  both the 100 ng and 10 ng dilutions of the VZV template. Only 
non-specific banding was observed with no visible product of the 
expected size on ethidium bromide-stained gels. Specific PCR product of 
the correct size was detectable in the 100 ng and 10 ng dilutions of the 
PRV template although many non-specific bands were also visible 
following gel electrophoresis.
In experiment 8B with 55°C annealing, PCR product was visible on 
ethidium bromide-stained gels in both the 100 ng and 10 ng dilutions of 
VZV and PRV templates. The presence of non-specific product was not 
evident in either of the samples.
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From these experiments it would appear tha t the lower annealing 
tem perature of 37°C has allowed annealing of the primers to both target 
and non-target sequences, however annealing a t 65°C in later cycles was 
possibly too stringent for further amplification of specific PCR product. 
In the second experiment with an  annealing tem perature of 55°C only 
specific product was detectable and therefore these cycling conditions 
were selected for use on DNA from a clinical sample.
5.2 .12. EXPERIMENT 9
Detection of HHV-6 and EBV in a DNA sample from a case o f AILD
In order to test whether the optimised conditions described in section
5.2.11.2. would be sufficient for the detection of herpesvirus sequences 
within a DNA sample from a clinical case, the following experiment was 
performed.
5.2 .12 .1 . PCR components and thermal cycling conditions
One hundred nanograms of DNA from a case of angioimmunoblastic 
lymphadenopathy (AILD) previously shown to contain HHV-6 type B and 
EBV by Southern blot analysis were used as template in each reaction. 
Detection of HHV-6 in this sample required a long exposure of the 
Southern blot to autoradiographic film. EBV was barely detectable on 
Southern blot analysis and was in fact initially scored as negative when 
a Bam HI-C probe specific for EBV was used. A Bam HI-W probe, from 
the internal repeat sequence of EBV, was required to detect the virus. 
PCR was performed in a 50 pL volume containing 2 pM of each primer. 
Hot S tart PCR was performed (section 5.2.5.2.J and all other reaction 
components were as stated in section 5.2.5.3. All possible primer 
combinations were used in a 96 well format as shown in Table V.XI.
Reactions were denatured in a Perkin-Elmer 9600 machine for 5 
m inutes a t 94°C. Samples were amplified under the optimised 
conditions described in section 5.2.10.2. Products of the PCR reaction 
were electrophoresed and ethidium bromide-stained (section 2.5.6.).
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Table V.XII. Primer combinations in a 96-well microtitre plate format
5’ primers 233-238 were added to 3' primers 201-216 in the 
combinations shown below.
233 234 235 236 237 238 233 234 235 236 237 238
201 201 201 201 201 201 209 209 209 209 209 209
202 202 202 202 202 202 210 210 210 210 210 210
203 203 203 203 203 203 211 211 211 211 211 211
204 204 204 204 204 204 212 212 212 212 212 212
205 205 205 205 205 205 213 213 213 213 213 213
206 206 206 206 206 206 214 214 214 214 214 214
207 207 207 207 207 207 215 215 215 215 215 215
208 208 208 208 208 208 216 216 216 216 216 216
5.2 .12 .2 . Results and conclusions
A PCR product of the predicted size was detectable on an  ethidium 
bromide-stained gel from reactions containing primer pairs 209/234 and 
212 /234  (Fig 5.6.A). The gel was electroblotted and hybridised to an  
HHV-6-specific gB probe (sections 2.5.7. and 2.4.4. respectively) derived 
from sequences internal to the primers and this confirmed th a t the 
sequences were HHV-6-specific (Fig 5.6.B). A gel containing PCR 
products from the primer set 207/236, which should have amplified 
EBV-specific product, was also blotted and hybridised to an  EBV-specific 
internal probe. Although PCR product of the expected size was not 
visible on the ethidium bromide-stained gel, specific EBV gB product 
was clearly detected following hybridisation.
The product of the PCR reaction using primers 209/234 was cloned 
(section 2.6.) and 4 clones were sequenced commercially (Alta- 
Bioscience). The sequence data confirmed the authenticity of the 
product, although primer usage was different from tha t expected from 
the published sequences of HHV-6.
This experiment clearly dem onstrates tha t this assay has the capability 
of detecting herpesvirus sequences present in DNA from a clinical
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F ig 5 .6 . Results obtained from a clinical DNA sample 
following PCR amplification as described in section 5.2.12. 
Primers used are detailed in the figure.
Fig A shows ethidium bromide-stained PCR products. Fig B 
shows the result obtained following hybridisation with an 
HHV-6 probe.
HHV-6 p ro b e  se q u e n c e :  5 ’GAC g tt  tag  c tt  tg t  g aa  c t c  c a c  g c c  t g a  3 ’.
Fig 5 .6 . D e tec tio n  of HHV-6 in  a c lin ica l DNA sam ple
A Ethidium bromide-stained gel.
3' primers as shown below. 5' primer 234. 
M 209  211 212
118 b p — >
72 b p  >
* indicates HHV-6 gB gene PCR product
B Hybridisation with an HHV-6 specific probe.
3' primers as shown below. 5' primer 234.
209  211 212
4.
sample. The sensitivity of the assay is highlighted by the fact tha t HHV- 
6 was detected in this sample by Southern blot analysis only following a 
long exposure of the autoradiograph, however HHV-6 specific gB product 
was clearly demonstrable on an  ethidium bromide-stained gel.
5.2 .13. EXPERIMENT 10
Comparison o f TaqStart and Ampliwax Hot Start PCR
As described in section 5.2.4.2. Ampliwax beads can be used to facilitate 
a Hot S tart for the PCR reaction. Hot S tart has been shown to improve 
the sensitivity of PCR when low copy num ber of target is present. The 
Hot S tart is therefore of critical importance in an  assay such as this 
where low viral copy num ber may be present in a  non-specific 
background. The Ampliwax beads have a disadvantage in tha t they are 
cumbersome to handle and this may lead to an  increased chance of 
contamination. Furthermore in this assay where there are 96 reactions 
the use of the Ampliwax beads can be time consuming. Recently an 
antibody to Taq polymerase (TaqStart, Clontech) has been made 
available for use in Hot Start PCR. The anti-Taq antibody binds to the 
enzyme rendering it inactive until the initial denaturing step of the 
reaction. In this experiment a comparison was made between Ampliwax 
and TaqStart antibody.
5.2 .13.1 . PCR components and thermal cycling conditions
DNA from the HHV-6 type A infected J -Jh an  cell line was used as 
template in each of these experiments. HHV-6 was an  ideal template for 
the reaction, as the calculated Tms of the primers required for 
amplification of this template were among the lowest in the overall 
primer set. If the annealing tem perature was too high for efficient 
annealing of the HHV-6 primers, then the assay would be inefficient.
A PCR reaction was performed in a 96-well format as described in 
section 5.2.12.1. One hundred | nanogram s of DNA from J-Jh an  cells 
infected with HHV-6 were used as template in each reaction. Ampliwax 
beads were used in the initial experiment to facilitate a Hot S tart and
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cycled at 55°C as described in section 5.2.11.1. In the following 
experiment TaqStart, a t a ratio of 28:1 antibody to enzyme, was used 
following the m anufacturers instructions and under identical reaction 
conditions as used with the Ampliwax. A further comparison was made 
using a ratio of 20:1 TaqStart to Amplitaq. Following therm al cycling 
products of the PCR reactions were assessed as described previously 
(section 2.5.6.). In addition products were subjected to dot-blotting as 
described below.
5.2 .13.2 . Dot-blotting o f PCR products onto nylon membrane
To streamline screening of PCR products with specific gB probes, 
products were denatured and subjected to dot-blotting onto nylon 
membrane (Amersham) using a 96-well dot blot manifold (Scotlab) 
following the m anufacturers instructions. The membrane-bound 
products were hybridised to an  end-labelled HHV-6-specific internal 
probe (section 2.4.3.) and washed under the appropriate conditions 
(section 2.4.4.). Comparisons of the electrophoresed ethidium bromide- 
stained products obtained and autoradiographs of hybridised dot blots 
were made.
5.2.13.3 . Results
On ethidium bromide-stained gels PCR product was detectable in 
reactions containing primers 209/234, 211/234  and 212/234.
Following hybridisation an HHV-6-specific oligonucleotide probe signal 
was clearly demonstrable in each of the above reactions. The typical 
results obtained for both Ampliwax and TaqStart reactions are shown in 
Fig 5.7.
Comparisons of autoradiographs from Ampliwax and TaqStart 
experiments were made. Hybridisation signal obtained was comparable 
for each of the experiments with Ampliwax and TaqStart. The 
m anufacturers recommend a 28:1 ratio of antibody to Amplitaq enzyme 
although suggest tha t titrations may be required. The results obtained
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Fig 5 .7 . Detection of HHV-6 in an HHV-6 type A infected cell 
line (J-Jhan). Fig A shows ethidium bromide-stained PCR 
products following amplification as described in section 
5.2.13.1. Fig B shows specific gB product following 
hybridisation with an HHV-6 probe. Results shown were 
obtained using Ampliwax beads. Experiments using TaqStart 
antibody were comparable to that shown.
HHV-6 p ro b e  se q u e n c e :  5 ’GAC g tt  t a g  c tt  tg t  g aa  c tc  c a c  g c c  t g a  3 ’.
Fig 5 .7 . D e te c tio n  of HHV-6 ty p e  A
A Ethidium  brom ide-stained gel of PCR products
<------1 1 8  bp
<— 7 2  bp
* indicates the positive result obtained with primers 209/234, 211 /2 3 4  and 212/234
B Hybridisation of dot-blot with an HHV-6 specific probe
3' primers below ; 5' primer 234  
209 210 211 212 213 214 215 216
•  # •
HHV-6 specific product detected with primers 209 /234 , 211 /234  and 212/234
3' primers as stated below; 5' primer 234  
209 210 211 212 213 214 215 216 M■
showed that a 20:1 ratio was satisfactory for our purposes and this was 
chosen as a  standard for further experiments.
In conclusion therefore the TaqStart product would appear to be a 
suitable substitute for Ampliwax beads within a  Hot S tart PCR. The use 
of TaqStart has greatly improved the handling and throughput of the 
assay.
5.2 .14. METAPHOR AGAROSE GEL ELECTROPHORESIS
Until this point, PCR products were electrophoresed on 8% 
polyacrylamide gels as described in section 2.5.6. The complete assay 
necessitated the use of 12 gels. Aside from being time consuming, the 
handling of large am ounts of acrylamide is potentially hazardous. 
Metaphor agarose is an  intermediate melting tem perature agarose with 
twice the resolution capabilities of the finest sieving agarose. A 4.0% 
agarose gel, equivalent to an  8% acrylamide gel in sieving qualities, was 
poured. Products from the complete assay were electrophoresed on a 
single large gel (Anachem) at 150 V for 1.5 hour. The gel was stained 
and resolution compared to acrylamide gel electrophoresed products. 
The results were not only comparable with acrylamide, bu t bands were 
sharper with no ’’smiling” apparent a t the edges of the gel.
The use of Metaphor agarose for the detection of PCR products following 
amplification with herpesvirus gB primers will greatly enhance the 
efficiency of the overall screening process.
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5 .3 . DISCUSSION
This study was designed to aid in the further investigation of known or 
as yet uncharacterised herpesvirus sequences th a t may be present in 
affected lesions of HD. The experimental data have shown tha t the 
assay has the capacity to detect herpesvirus gB sequences if 1 copy of 
the herpesvirus genome is present in 1% of cells within a tissue mass. 
This sensitivity has been achieved using ethidium bromide-stained gels 
for the detection of PCR product and not following hybridisation of 
product with specific probe. This is of param ount importance in a  study 
such as this in which we wish to identify new or as  yet uncharacterised 
sequences for which no specific probes are available.
The sensitivity of the assay was initially assessed utilising an  EBV- 
positive DNA sample as template and further optimised with a range of 
herpesvirus templates. Numerous comparative experiments were 
performed for the optimisation of both reaction and therm al cycling 
conditions. The assay has been validated by the detection of two 
different herpesvirus genomes within a clinical DNA sample previously 
investigated for the presence of theses viruses by Southern blot analysis. 
The herpesvirus gB sequences within this case were shown to be EBV 
and HHV-6 on the basis of preferential primer usage and confirmed by 
hybridisation with type specific internal oligonucleotide probes. The 
HHV-6 specific product was clearly visible following ethidium bromide- 
staining and hybridisation with an  HHV-6 probe specific for the region 
internal to the primer sequences. The authenticity of the product was 
further confirmed by cloning and sequencing. HHV-6 had previously 
been dem onstrated in this case following Southern blot analysis and 
hybridisation to the 9 kb HHV-6 probe pZVH14. Hybridisation to this 
probe gave rise to a weak signal following exposure to radiographic film. 
This em phasises the sensitivity of the PCR assay.
To enable the detection of a low copy num ber of herpesvirus sequences 
within template DNA, 60 cycles of PCR amplification were performed in 
th is assay. A problem associated with increased cycle num bers within a 
PCR reaction is the increase of non-specific products. The use of 
degenerate primers may further augm ent this problem. Despite 
extensive experiments for the optimisation of therm al cycling conditions,
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non-specific product was apparent using many primer sets. When 
known viral sequences are present in template DNA, PCR product is 
clearly detectable in the expected size range and therefore can be 
distinguished from non-specifically primed product. However, an 
experimental PCR system where sensitivity of the assay is maintained 
and a  reduction in background priming is achieved would be 
advantageous. To achieve this goal a sensitive autom ated detection 
system such as tha t described in section 5.2.6.2. may enable a reduction 
in cycle num bers and therefore an  eventual decrease in non-specific 
fragments within the PCR. This would allow more discrimination in the 
selection of PCR products for further investigations such as cloning and 
sequencing.
The recent purchase of an  automated DNA sequencer (DNA 4000 
sequencer, Licor) within the Department of Veterinary Pathology has 
enabled the use of 5' infra-red labelled primers for PCR amplification. 
The resulting infra-red labelled PCR products can be detected on the 
automatic sequencer using a laser scanner. This detection system 
employs similar methodology to the fluorescein-labelled detection system 
described previously. The sophisticated software will allow more 
accurate sizing of PCR products for selection and further 
characterisation. In addition, num erous samples can be analysed 
simultaneously and this will increase efficiency and throughput of the 
assay. Preliminary experiments suggest tha t the detection of PCR 
products using this technology is superior to the sensitivity found by 
conventional ethidium bromide-staining. This detection system may 
enable a reduction in cycle num bers while maintaining the necessary 
PCR reaction sensitivity. The presence of non-specific product may 
therefore be reduced or eradicated utilising the autom ated system. 
Further experiments are required to assess these predictions.
An additional advantage of an  automated system for PCR product 
analysis, is tha t it will enable the use of 7-deaza-2' deoxyguanosine 
(c7dGTP) within the PCR. Compton (1990), used c7dGTP in their PCR 
reactions combined in a dGTP mixture, to combat problems associated 
with GC rich regions of target DNA. McConologue et a l t (1988) have 
dem onstrated tha t the use of c7dGTP is vastly superior in PCR reactions 
with difficult templates and allows increased specificity. When designing
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our primers we did not include c7dGTP, because although the overall 
efficiency of reactions is not affected, intercalation of ethidium bromide 
is hindered and results in less efficient detection of amplified DNA. The 
use of an  automated gel system may dispense with the need for ethidium 
bromide staining of PCR products and therefore the inclusion of c7dGTP 
in the assay may enhance sensitivity and specificity in future 
experiments. More recently Weiss et a l, (1994), have described the use 
of silver staining for the detection of reactions containing c7dGTP. In 
contrast to ethidium bromide-staining, the binding of silver ions is not 
impaired by c7dGTP. This is therefore another detection method which 
merits investigation, when c7dGTP is substituted for conventional dGTP 
within our PCR reactions.
The nested analysis discussed in section 5.2.6.3. will allow small DNA 
samples from HD biopsy specimens to be investigated for the presence of 
herpesvirus sequences.
At present this assay has been shown to have the sensitivity required to 
investigate clinical DNA samples for the presence of herpesvirus gB 
sequences. Utilising this assay HD samples can be screened for the 
already characterised herpesviruses by using type specific internal gB 
probes. Any visible PCR product of the expected size, tha t does not 
hybridise with the known probes can be cloned for sequencing and 
further investigation. This assay may lead to the identification of a 
different herpesvirus in the non EBV-associated cases of HD.
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CHAPTER 6
GENERAL DISCUSSION
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The aetiology of HD is not known. Viruses are thought to play a  key 
role, however in common with other malignant diseases it is likely that 
other factors e.g., oncogene activation are also involved. EBV has been 
detected in around 40% of HD cases (section 1.4.1.). EBV LMP-1 is 
expressed by the RS cells in EBV-positive cases. The paediatric and 
older age groups of HD are frequently EBV-associated. In contrast, the 
young adult group particulary of the NSHD subtype have not been 
associated with EBV (section 1.4.1.1.).
At the sta rt of this work it had been shown tha t the t(14;18) 
translocation was present in tum ours from HD cases (Chapter 3). LMP-1 
has been shown to upregulate Bcl-2 protein expression, and therefore 
the potential induction of bcl-2 by the t(14;18) translocation or by LMP-1 
in EBV-associated cases suggested tha t increased Bcl-2 expression 
might be playing a role in the pathogenesis of HD (section 1.4.4.1.). 
Results obtained from our study indicate tha t the t(14;18) translocation 
is an  infrequent finding in HD. In addition no correlation between LMP- 
1 positivity and Bcl-2 expresssion was noted. Other studies have 
corroborated these findings as discussed in section 3.3. The t(14;18) 
translocation detected in HD tum our tissue may have been present in 
the reactive component of these tum ours. This suggestion is certainly 
feasible as Bcl-2 expression can be detected in normal lymph node 
tissue (section 1.6.). In a further study LMP-1 expression appeared to be 
independent of both CD23 and Bcl-2 expression in EBV-positive HD 
tum our samples (Armstrong et a l, 1992a). In conclusion the t(14; 18) 
translocation is infrequently found in association with HD and Bcl-2 
expression would appear not to be a critical event in the pathogenesis of 
the disease. The exact role of LMP-1 in the pathogenesis of the EBV- 
associated cases of HD disease remains unclear.
An animal model for the propagation of the malignant cells of HD would 
be advantageous for subsequent investigation and characterisation of 
the RS cell. The SCID mouse model has been shown to be a useful tool 
in the investigation of a num ber of hum an malignancies (section 1.6.). 
The results obtained from our study showed that, although the 
propagation of NHL tissue was readily supported in  the SCID 
environment, growth of the malignant cells from HD tum our tissue was 
unsuccessful. Tumours obtained in the SCID model following injection
i l l
of HD tum our tissue resembled EBV-driven lymphoproliferations as 
observed in studies following engraftment of PBMCs from EBV- 
seropositive donors. Relatively few studies have attem pted the growth of 
HD tum ours in SCID mice and therefore further studies such as that 
detailed in Chapter 4, are needed to arrive a t definitive conclusions on 
the use of such a strategy for HD research. At present, however, the 
SCID model would not appear to be a suitable system for the 
propagation of HD-derived tum our material. The problems observed in 
our study may be due to the lack of the functioning immune system in 
the SCID mouse as cell-cell interactions may play an  im portant role in 
the pathogenesis of HD.
The difficulty in the growth of HD tum our tissue in vivo, as described 
above, and in vitro has impaired both the immunophenotypic and 
genotypic analysis of the disease. As previously discussed, the relative 
paucity of malignant cells present within the tum our m ass has impaired 
the characterisation and investigation of the RS cell (section 1.2.4.). 
PCR is a  sensitive technique widely used for the detection of DNA 
sequences. This can be applied to single cells a t both the DNA and RNA 
level. The advent of sensitive techniques such as single cell PCR 
analysis has enabled more specific studies to be performed. The 
technique has been used for the study of IgH gene rearrangem ents in the 
RS cells of HD cases (Kuppers et aL, 1994). Studies like this enable 
characterisation of the RS cell away from the reactive component of the 
tum our mass. This technique has also been used to dem onstrate p53 
m utations within the RS cells of HD tum our specimens and suggests 
tha t the p53 gene may play an aetiological role in the disease (section 
1.2.6.). Further studies are required to clarify the significance of this 
finding however the use of single cell PCR for the investigation of RS cells 
in HD may prove to be invaluable.
In a  recent study of HD tum our tissue quantitative PCR analysis has 
revealed an  association between the t(2;5) translocation and the disease 
(Orscheschek et a t, 1995). This translocation is often found in T-cell 
derived anaplastic large cell lymphoma which morphologically and 
immunohistochemically resembles HD (Agnarsson & Kadin, 1988). The 
translocation results in a fusion product with tyrosine kinase activity 
which may regulate cell growth and be involved in tumorigenesis. The
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authors suggest tha t t(2;5) may be used as a  clonal m arker In a 
proportion of HD cases.
The young adult peak observed in HD, in particular the HDNS subtype is 
non EBV-associated. Epidemiological studies suggest tha t this group of 
cases may have an  infectious aetiology (section 1.2.5.). In order to 
investigate HD tum our tissue for the presence of herpesvirus sequences, 
in particular the non EBV-associated cases, a  PCR strategy was devised. 
As discussed in Chapter 5 this assay has the sensitivity to detect 
herpesvirus sequences present in RS cells. In addition the assay has the 
capability of distinguishing different herpesviruses. This is of particular 
importance in HD tum our tissue where different herpesviruses may be 
present in both the RS cell an d /o r the reactive component of the 
tumour.
The primers for this assay were based on two well conserved 
penatapeptide regions of herpesvirus gB genes. The gB sequence of an  
additional herpesvirus, the canine herpesvirus, was recently published 
(Limbach et aJL, 1994). On examination of the amino acid sequence of 
the canine gB gene the conserved regions, from which the primers of our 
assay are based, were present. This highlights the highly conserved 
nature of these sequences in gB genes across the herpesvirus family, 
and confirms the potential use of th is assay for the detection of new or 
as yet uncharacterised herpesvirus sequences.
Section 5.3. discussed the possible use of an  autom ated screening 
system for the detection of PCR derived products utilising infra-red- 
labelled primers. Preliminary experiments suggest tha t the overall 
sensitivity of this methodology is superior to ethidium bromide-staining. 
This may enhance detection of viral sequences a t low copy num ber and 
possibly decrease the am ount of template DNA required. Samples 
enriched for RS cells, or pooled single RS cells used as template in this 
reaction, may reveal a new or as yet uncharacterised herpesvirus in the 
non-EBV associated cases of HD.
The studies described above emphasise that PCR is a useful tool in the 
investigation of tum our tissue. Many different applications have been 
described utilising PCR technology however most noteworthy in this
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context is the discovery of a new hantavirus, which is the suspected 
aetiological agent of the newly identified respiratory disease syndrome 
(Hjelle et aL, 1994). The virus was isolated using primers designed to 
conserved regions of previously characterised hantaviruses and 
highlights the use of PCR technologies based on conserved regions of 
known genes for the identification of novel agents.
The herpesvirus gB assay will be used alongside other molecular 
techniques for the detection of unknown viral sequences. One such 
technique known as representational difference analysis has been 
described where differences between two genomes can be isolated and 
cloned utilising a PCR based methodology (Lisitsyn et aL, 1993). 
Preliminary results obtained within our laboratory suggest tha t this is a 
promising technique for the isolation of viral sequences (personal 
communication, J . MacKenzie). Recently this technique has enabled the 
identification of herpesvirus-like DNA sequences from patients with 
Kaposi’s sarcoma, the most common neoplasm occurring in persons with 
AIDS (Chang et a t , 1994). The study concludes tha t the herpesvirus 
sequences detected may prove to be a new herpesvirus although the 
exact relationship between virus and disease has yet to be clarified. The 
possible discovery of a new herpesvirus supports the notion tha t as  yet 
uncharacterised herpesviruses exist and may be associated with other 
malignancies.
In conclusion, the exact nature of the RS cell in HD rem ains an  enigma 
and the role of viruses within the disease is not clear. However, the 
advances made in recent years in HD studies and the advent of 
sophisticated technology for subsequent investigations, may ultimately 
answer the unresolved issues.
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